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1. Introduction 
1.1. Archaea 
1.1.1. The third domain of life 
In the early 1990s the common view upon phylogeny and taxonomy dramatically 
changed. Up to that point in time two major models for the evolutional 
relationships between all organisms were conventionally accepted. On the one 
hand the five kingdom model, which had been developed from the mid 1860s, 
introduced by Ernst Haeckel (Haeckel, 1866), throughout the twentieth century 
during which this theory was rounded up by Copeland (Copeland, 1938) and 
Whittaker (Whittaker, 1959). In its latest form, which also became known as the 
“Whittaker Scheme”, it categorizes all life forms either as Animalia, Plantae, 
Fungi, Protista or Monera (Whittaker & Margulis, 1978). On the other hand there 
stood a far more radical theory introduced by Eduard Chatton. He proposed only 
two major categories of life based on the absence or presence of a cellular  
nucleus – the prokaryotes and the eukaryotes (Chatton, 1938). This dichotomy 
later on became more and more supported by the accumulation of evidence 
gathered by the utilization of the ever higher developing methods of biochemistry 
and molecular microbiology. “However, the eukaryote prokaryote concept itself has 
been seriously misunderstood and, consequently, wrongly interpreted.” (Woese et 
al., 1990). A major mistake was buried in the assumption, that all the prokaryotes 
constitute a monophyletic group (Woese et al., 1990). By analysis of ribosomal RNA 
sequences of various “bacterial strains” it was found that amongst this domain a 
small group of bacteria displayed major differences in comparison with other 
prokaryotes. This group by that time comprising only a small number of 
methanogenic bacteria was termed Archaebacteria (Woese & Fox, 1977). Further 
comparison of the small subunit rRNAs of eukaryotes, prokaryotes and 
archaebacteria eventually led to the rearrangement of the universal phylogenetic 
tree and to the introduction of a whole new three domain theory dividing all 
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organisms into Bacteria, Archaea and Eukarya (Woese et al., 1990).  Amazingly the 
newly introduced domain of Archaea seemed to share with the Eukarya a common 
ancestor while the Eubacteria seemed to branch earlier in time thus making 
Eukarya and Archaea, though distant, specific relatives (Woese et al., 1990). 
1.1.2. Archaeal diversity 
Originally it was believed that the domain of Archaea comprises a rather exclusive 
group of microorganisms, which mainly inhabit extreme environments but it soon 
became clear that Archaea are in fact widespread (Olsen, 1994). For example a 
recent study of archaeal and bacterial abundance in the Pacific Ocean suggests 
that the global oceans harbor approximately 1.3 x 1028 archaeal cells and 3.1 x 1028 
bacterial cells and that the phylum Crenarchaeota alone accounts for 20 % of all 
the picoplankton cells in the oceans (Karner et al., 2001). Thus the so called “third 
domain of life” contributes a significant, not to say crucial amount of earth´s 
biomass. 
Based upon the 16S rRNA analysis the domain Archaea currently consists of two 
phyla (according to Bergey´s manual (Garrity et al. (eds), 2001)) that are commonly 
accepted – the Euryarchaeota and the Crenarchaeota (Woese et al., 1990).  While 
the Euryarchaeota “…encompass the greatest phenotypic diversity among known 
cultivable species, with the halophiles, the methanogens, some thermoacidophiles 
and some hyperthermophiles” (Forterre et al., 2002) the Crenarchaeota so far 
comprise only hyperthermophilic species (Forterre et al., 2002). However additional 
archaeal phyla like the Korarchaeota (Barns et al., 1996) and the Nanoarchaeota 
(Huber et al., 2002; Huber et al., 2003) have also been suggested indicating that the 
current classification of the domain of Archaea is certainly not the end of the 
tunnel. Eventually this classification could end up looking much more similar to 
that of the Bacteria in terms of the diversity of phyla (Forterre et al., 2002).  
Although a common view of archaeal abundance is that they are in fact 
predominant in extreme habitats (e.g. high or low pH, high salt, high pressure) this 
assumption cannot be accounted fully true since Bacteria (and even some Eukarya) 
have also been found residing side by side with members of Archaea even under 
extreme conditions – so far only to one exception – hyperthermic environments 
above 95° C (Rothschild & Mancinelli, 2001; Forterre et al., 2002). Another 
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widespread opinion is that Archaea are mostly extremophiles which is due to the 
fact that the first characterized Archaea were found to live under extreme 
conditions (Valentine, 2007).  However, as stated above, the findings of Karner et 
al. and others changed the view of Archaea being restricted only to extreme 
habitats. Yet, the altering view does not diminish the interest in this domain, as in 
many extreme habitats Archaea play the dominant role and are still the record 
holders for growth at the highest temperature, lowest pH, and highest NaCl 
concentration (Chaban et al., 2006). Thus the importance of archaeal life in these 
environments remains unquestioned. 
 
  
Figure 1| The three domains of life. One of many visualizations of the phylogenetic tree of 
life based on 16S rRNA sequence comparison showing  the Archaea and the Eukarya sharing a 
common ancestor. Among the Archaea the Euryarchaeota and the Crenarchaeota are commonly 
accepted according to Bergey´s manual (Garrity et al. (eds), 2001) with the Euryarchaeota 
exhibiting the greatest diversity. Currently all cultivable Archaea belong to these two phyla. 
However, other phyla have been suggested. The phylum Korarchaeota has been proposed only 
on the basis of 16S rRNA analysis (Barns et al., 1996) whereas the Nanoarchaeota so far 
comprise only one genus, Nanoarchaeum equitans, which exhibits extraordinary small cell 
sizes of approx 0.5 µm (Huber et al., 2003). 
(Allers and Mevarech, 2005) 
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As far as metabolic diversity is concerned Archaea and Bacteria seem to match 
each other – with one exception: methanogenic organisms have so far only been 
described within the domain of Archaea (Forterre et al., 2002). All other metabolic 
pathways comprising heterotrophy, autotrophy and photosynthesis have been 
found in both domains Archaea and Bacteria (Forterre et al., 2002).  
1.1.3. Molecular characteristics of the Archaea 
Archaea are not only distinguished from Bacteria and Eukarya by their 16S rRNA 
sequence. They also exhibit certain unique features which cannot be found in the 
two other domains. On the other hand some of their features are more closely 
related to the Eukarya whereas others seem to be reminiscent of Bacteria. 
1.1.3.1. Structural features 
In terms of cell sizes both Archaea and Bacteria are relatively similar. However, 
the membrane lipids of Archaea provide a substantial criterion for their distinction 
from the other two domains of life. Their glycerolipids are ethers of glycerol and 
isoprenol, while in Bacteria and Eukarya lipids exhibit esters of glycerol and fatty 
acids (Forterre et al., 2002). These glycerol ethers contain 2,3-sn-glycerol instead of 
1,2-sn-glycerols found in Bacteria and Eukarya (Brown & Doolittle, 1997). In 
addition to that “…archaea have highly methylbranched isopranyl chains, while 
hydrocarbons in bacteria and eukaryotes are predominantly straight-chain fatty 
acyl chains.” (Brown & Doolittle, 1997). Furthermore the domain of Archaea is 
characterized by the total lack of peptidoglycan, which is compensated in some 
species by the presence of pseudopeptidoglycan (e.g. members of the 
Methanobacteriales) or heteropolysaccharides (e.g. Halococcus) (Brown & Doolittle, 
1997). The pseudopeptidoglycan shows fundamental differences to the bacterial 
peptidoglycan. It contains L-talosaminuronic acid instead of muramic acid and 
D-amino acids are not found in the peptide moiety (Kandler & König, 1998).  
Besides that many members of the Archaea possess only proteinaceous or 
glycoproteinaceous cell envelopes (S-layers) or only have a cytoplasmic membrane 
containing glycoproteins (e.g. Thermoplasmatales) (Kandler & König, 1998; 
Forterre et al., 2002).  
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The vast differences between bacterial and archaeal cell wall structure and 
synthesis are also reflected by their different susceptibility to certain antibiotics. 
So it seems only natural that classic antibiotics that are directed against bacterial 
cell wall synthesis like the β-lactams (e.g. penicillin) have virtually no effect on 
archaeal growth (Kandler & König, 1998). Thus the number of antibiotics effective 
against members of the Archaea is limited with certain antibiotics being more 
restricted to smaller groups of them. 
1.1.3.2. Genomic features 
At the first glance the genomic organization of Archaea resembles that of Bacteria. 
The DNA is organized into a, sometimes large, circular chromosome accompanied 
by one or more smaller circular DNA plasmids (Brown & Doolittle, 1997). Yet the 
packaging of the DNA in the archaeal cell is more reminiscent of Eukarya in a 
variety of ways as they possess histones. So far, however, these DNA binding 
proteins have only been found in the Euryarchaeota. In Archaea the histones are 
shorter than in Eukarya and lack the N- and C-terminal tail extensions (White & 
Bell, 2002). Another difference to eukaryotic histones is that in Archaea they can 
not only form heterodimers (like in eukaryotes) but also homodimers. In addition to 
that, Archaea also have DNA compacting proteins, similar to bacterial HU (White 
& Bell, 2002; Brown & Doolittle, 1997). 
Archaeal genes are often organized into operons like in Bacteria (Brown & 
Doolittle, 1997). Considering these similarities it was initially believed that like in 
Bacteria archaeal chromosomes also contain only one origin of replication. 
However, recently Sulfolobus Solfataricus has been shown to possess three origins 
of replication (Lundgren et al., 2004).  
1.1.3.2.1. DNA replication 
In general DNA replication in Archaea seems to be more related to that of Eukarya 
than to that of Bacteria. In Bacteria the protein DnaA binds to the origin of 
replication and initiates melting of the complementary DNA strands, in order to 
initiate replication. In Archaea homologues to the eukaryotic initiator proteins Orc 
and Cdc6 have been identified in almost all of the currently sequenced archaeal 
genomes (Barry & Bell, 2006). Helicases, proteins responsible for unwinding of the 
DNA, which is done in Bacteria by a protein called DnaB, are found to be 
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homologous in Archaea and Eukarya. Furthermore while Primer synthesis in 
Bacteria is achieved by a protein called DnaG, in Eukarya and Archaea the same is 
done by family B polymerases (Edgell & Doolittle, 1997). Also archaeal and 
eukaryal DNA polymerases are homologues and not related to any bacterial DNA 
polymerase except that of E.coli (Brown & Doolittle, 1997). However, in addition to 
family B DNA polymerases which are responsible for strand elongation in Archaea 
and Eukarya a novel family of DNA polymerases, subsequently named family D 
DNA polymerases, has been found in euryarchaeal genomes. These new 
polymerases so far seem to be unique to the Euryarchaea, though (Barry & Bell, 
2006).  
1.1.3.2.2. Transcription 
The transcription of archaeal genes constitutes a mosaic of eukaryal and bacterial 
features. Although Archaea, like Bacteria seem to have only one RNA polymerase 
the subunit complexity of this enzyme is similar to that of Eukarya (Bell & 
Jackson, 1998). Latter feature three different RNA polymerases which transcribe 
different sets of genes. However, all three of these show significant structural 
similarities to archaeal RNA polymerases (Brown & Doolittle, 1997). Furthermore 
phylogenetic studies show that the large subunits of the archaeal enzyme are 
closely related to the eukaryal RNA polymerase II. Archaeal promoter elements are 
also reminiscent of Eukarya as they contain TATA box like binding sites, usually 
situated about 30 bp upstream of the transcription initiation (Bell & Jackson, 
1998). The recognition of the TATA like element occurs by a homologue to the 
eukaryal TATA box binding protein (TBP). Other eukaryotic transcription factors, 
like TFB or TFIIS are also found to have homologues in Archaea (Bell & Jackson, 
1998). Interestingly archaeal RNA polymerase requires only two transcription 
factors (TBP, TFB) for initiation in vitro, in contrast to eukaryal RNA 
polymerase II, which additionally requires TFIIE, TFIIF and TFIIH (Bartlett, 
2005).  
Transcriptional elongation in Archaea however is less well understood, than 
initiation since as stated above, eukaryotic TFIIS homologues have been found in 
Archaea. It exhibits homologies to eukaryotic TFIIS as well as to eukaryotic RPB9 
(a subunit of eukaryal RNA polymerase II, with homologues in the other two 
eukaryal RNA polymerases) and has been shown to be able to induce a cleavage  
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activity in the RNA polymerase, as TFIIS does in Eukarya (Lange & Hausner, 
2004). This is important to improve the fidelity of transcription and to rescue and 
prevent arrested elongation (Lange & Hausner, 2004). Along with TFIIS also 
homologues of bacterial elongation factors NusA and NusG have been identified, 
leaving the possibility that transcriptional elongation in Archaea may be also 
closely related to Bacteria (Bell & Jackson, 1998). 
1.1.3.2.3. Translation  
In Archaea the processes involved in the translation of mRNA for protein 
biosynthesis seem also to be a mixture of eukaryal and bacterial features. As in 
Bacteria archaeal genes do not contain introns but since lower eukaryotes also do 
not necessarily seem to have introns as well the absence or presence of spliceable 
elements should not be regarded as a typically prokaryotic or eukaryotic feature, 
respectively (Brown & Doolittle, 1997). On the other hand archaeal mRNAs are not 
5´ capped like eukaryal ones and in many cases (but not always) they possess a 
Shine Dalgarno (SD) like sequence, similar to that of Bacteria. Furthermore 
Archaea exhibit 70S ribosomes, which contain ribosomal RNA (rRNA) components 
reminiscent to that of Bacteria in number and sizes (23S rRNA, 16S rRNA, 5S 
rRNA) (Brown & Doolittle, 1997). However, while Bacteria are susceptible to 
streptomycin, an anti 70S ribosomal inhibitor, Archaea as well as Eukarya are 
unaffected by such antibiotics, whereas susceptible to certain anti 80S ribosomal 
inhibitors (like anisomycin) (Brown & Doolittle, 1997). Initiation of translation in 
Archaea is performed by factors that are homologous to eukaryal ones, like eIF-1A, 
eIF2, eIF2B, eIF-4A (though for eIF-2B the eukaryotic version is more complex). 
Factors involved in the recognition of the 5´ cap of eukaryal mRNAs are missing in 
Archaea, which is consistent with the fact that Archaea lack the 5´ caps (Bell & 
Jackson, 1998). Another noteworthy characteristic is that Archaea, like Eukarya 
are using initiator tRNAs carrying methionine and not N-formylmethionine as is 
known for Bacteria (Keeling & Doolittle, 1995). On the other hand the recognition 
of the translational start sites resembles that of Bacteria. The Shine Dalgarno 
sequence is situated about 3 – 10 nucleotides upstream of the start codon (which is 
most frequently AUG, as in Bacteria) and exhibits a sequence complementary to 
the 3´ end of the 16S rRNA. Thus the start codon comes close to the anticodon of 
the initiator tRNA (Bell & Jackson, 1998). Elongation of the polypeptide chain is 
mediated also by factors homologous to eukaryal elongation factors such as eEF-1α, 
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which is responsible for recruitment of the aminoacyl tRNAs to the A-site of the 
ribosome, or eEF-2, which is involved in translocation of the ribosome. Recognition 
of stop codons is then, yet again, achieved by a single factor that shares similarities 
to eukaryotic release factors (Bell & Jackson, 1998).  
As a conclusion, considering all these characteristics, Archaea in many ways seem 
to exhibit simplified versions of eukaryal features. On the other side they share 
significant similarities with Bacteria. This underlines their fundamental 
importance for understanding evolutionary relationships between the domains of 
life, as well as evolution as a whole. 
1.1.4. Haloalkaliphilic Archaea 
Haloalkaliphilic organisms face both high salt concentrations as well as a high pH. 
These organisms are found in all three domains of life. Herein only the properties 
of the Archaea and their adaptation to high salt and high pH conditions will be 
considered subsequently. 
1.1.4.1. Diversity of halophilic Archaea 
The Halobacteriaceae of the order Halobacteriales constitute the model halophilic 
microorganisms and contribute the largest part of microbial biomass in habitats as 
the Dead Sea, hypersaline soda lakes (such as Lake Magadi, Kenya) and saltern 
crystallizer ponds. Furthermore these microbes are almost solely responsible for 
the reddish color of such lakes since the membranes of many halophilic species 
hold large concentrations of C-50 carotenoid pigments, like bacterioruberin and its 
derivatives (Oren, 2002). In addition to that also the methanogens of the 
Euryarchaeota contain halophilic species and methanogenesis was found to take 
place even at nearly saturated salt concentrations. However within the kingdom 
Crenarchaeota no halophiles have been identified so far (Oren, 2002).  
1.1.4.2. Halophily – living under high salt conditions 
 There is currently no unifying definition of where halophily starts. All (micro-) 
organisms have a minimum amount of NaCl that they require for growth, as well 
as an optimum, where they grow best and a maximum of NaCl that they can 
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tolerate. Based upon this fact Donn Kushner established three different categories 
for halophiles: “extreme halophiles (growing best in media containing 2.5–5.2 M 
salt), borderline extreme halophiles (growing best in media containing 1.5–4.0 M 
salt), moderate halophiles (growing best in media containing 0.5–2.5 M salt), and 
halotolerant microorganisms that do not show an absolute requirement for salt for 
growth but grow well up to often very high salt concentrations (considered extremely 
halotolerant if the growth range extends above 2.5 M salt)” (Kushner, 1978; Oren, 
2008). 
The majority of the halophilic Archaea belongs to the order of Halobacteriales. 
Within this order most of the species could be classified as extremely halophilic, 
according to Kushner´s definition. In addition to that also within the 
Methanosarcinales halophilic or at least highly halotolerant organisms have been 
found. It is also worth mentioning, that all archaeal species categorized as 
halophiles so far belong to the phylum Euryarchaeota (Oren, 2008).  
1.1.4.2.1. Adaptations to high salt concentrations 
In principle adaption to high salinity implies that the cytoplasm is at least 
isoomotic with the surrounding medium. There are two fundamental strategies to 
achieve this: (i) Accumulation of high molar concentrations of salt, usually KCl, 
inside the cell in order to maintain intracellular water activity. This however also 
requires the adaption of the complete proteome to these conditions, leaving no 
possibilities for surviving under low salt conditions. This technique is also referred 
to as “high-salt-in strategy” (Oren, 1999; Oren, 2008). (ii) Biosynthesis and/or 
uptake of organic osmotic solutes also allows for coping with high extracellular salt 
concentrations. This strategy is also called “compatible-solute strategy” and does 
not necessarily involve specially adapted proteins. There is a large variety of such 
compatible solutes, which ranges from polyols like glycerol, over certain sugars to 
amino acids and quaternary amines (Oren, 1999; Oren, 2008).  Whatever strategy 
is used, there have to be potent mechanisms for extruding Na+ from the interior of 
the cell. All halophilic microorganisms seem to have such a mechanism usually 
based upon Na+/H+ antiporters (Oren, 2002). 
Though the compatible-solute strategy seems to be the most widespread in nature, 
the high-salt in strategy is most common in Archaea, especially in the extremely 
halophilic family of the Halobacteriacae (Oren, 1999; Oren, 2008). 
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1.1.4.2.1.1. Properties of halophilic proteins  
Many halophilic proteins exhibit a large excess of acidic amino acid residues. This 
fact is important since electrostatic effects are significantly contributing to protein 
folding and stability (Lanyi, 1974). Normally one would assume, that a large 
number of similar charges in macromolecules, favors protein unfolding due to 
electrostatic repulsion yet it has been shown that residue linkages as well as 
disulfide interactions are indeed capable of overcoming the electrostatic force. On 
the other hand it has been suggested that the need of halophilic proteins for high 
concentrations of cations is due to the screening of negatively charged residues 
(Lanyi, 1974). This theory has been at least partially supported by experiments in 
which the high concentrations of monovalent cations, usually found within the cells 
of extreme halophiles, were exchanged by lower concentrations of divalent cations, 
without losing significant protein stability and activity. However, the requirement 
of high salt concentrations of halophilic proteins cannot be exclusively explained by 
this theory, since halophilic enzymes also exhibit specificity for certain anions 
(Lanyi, 1974). For example it has been observed that the activity of 3-hydroxy-3-
methylglutaryl-coenzyme A reductase from Haloferax volcanii increases with rising 
concentrations of KCl, while it decreases when the concentration of NaCl is raised 
(Madern et al., 2000).  
There are also some other effects of high salinity that have to be taken into 
consideration, in order to understand why halophilic proteins are able to function 
in such extreme environments. With increasing concentrations of salt, new 
hydrophobic interactions are beginning to form, which were not stable enough 
before. Thus the protein becomes more tightly folded (Lanyi, 1974). Therefore 
halophilic proteins contain a low amount of hydrophobic amino acids, resulting in 
the need for high salinity in order to maintain these hydrophobic interactions 
(Fendrihan et al., 2006). Furthermore local residues play a significant role, as they 
seem to be influenced under halophile conditions, (i) through structural changes or 
(ii) through direct effects on the residues themselves (Lanyi, 1974).  
1.1.4.3. (Halo-) alkaliphilic Archaea 
As it is for halophilism, there is also no common definition for alkaliphily. Usually 
organisms that have their growth optimum at around or above pH 9 are considered 
to be alkaliphile. Alkaliphiles can be further subdivided into alkaliphiles and the 
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haloalkaliphiles (Horikoshi, 1999). The latter have been observed to live in high 
salt and high pH environments like the lakes situated along the east African rift 
valley (e.g. Lake Elmenteita or Lake Magadi) and the western soda lakes of the 
United States. Hypersaline soda lakes like Lake Magadi (Kenya) or the Wadi 
Natrun (Egypt) are the natural habitat for the alkaliphilic members of the 
halophilic Archaea, where they show titers up to 107 – 108 cells/ml (Horikoshi, 
1999).  
1.1.4.3.1. Adaptations to high pH 
Although alkaliphilic microorganisms live in environments that exhibit a high pH, 
the intracellular pH of these organisms has not necessarily to be high as well. 
There are various ways to measure the cytoplasmic pH inside the cell. For the 
α-galactosidase of alkaliphile Micrococcus sp. strain 31-2 (a representative of the 
Bacteria) the optimal pH for activity of this enzyme has been shown to be 7.5 
suggesting that the internal pH of the cell is around neutral (Horikoshi, 1999). In 
addition to that in vitro protein synthesis systems from alkaliphiles show best 
activity at pH 8.2 – 8.5, which is only marginally higher than in B. subtilis 
(Horikoshi, 1999). Furthermore it is possible to measure the distribution of weak 
bases (which are not actively transported by the cell) within and outside the cell. In 
doing so it has also been found that the internal pH of the observed organisms lays 
around 8, although outside in the surrounding media it is far higher (Horikoshi, 
1999). These facts lead to the conclusion, that the cell walls and cell membranes of 
alkaliphilic organisms are crucial for their survival in such extreme environments, 
as they separate the rather mesophile pH of the interior of the cell from the highly 
alkaline pH in the surrounding media (Horikoshi, 1999). 
The cell walls of alkaliphilic microorganisms often contain acidic polymers. They 
provide additional negative charges that are capable of adsorbing Na+ and H3O+ 
ions but repulsing OH– ions. Thus the pH on the very surface of the cell may be 
considerably lower than in the surrounding media (Horikoshi, 1999). The cell wall 
of the highly alkaliphilic archaeon Natronococcus occultus contains 
glutaminylglycan, a glycoconjugate of two oligosaccharides that are linked to a 
backbone of poly-γ-L-glutamine via their α-amide group. One of which consisting of 
GalNAc and Glc, the other consisting of GlcNAc and GalA (Kandler & König, 1998). 
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To regulate intracellular pH aerobic alkaliphiles use Na+/H+ antiporters in addition 
to H+ -coupled respiration. These antiporters generate a proton motive force based 
on both the transmembrane pH gradient (ΔpH) and the transmembrane electrical 
potential (Δψ) (van de Vossenberg et al., 1999). For the majority of haloalkaliphiles 
the sodium concentration in the surrounding medium is high, while the 
concentration of H+ is low. The Na+/H+ antiport reaction is responsible for both the 
extrusion of sodium ions from and the uptake of H+ into the cytoplasm (van de 
Vossenberg et al., 1999). Obviously this mechanism would be negatively influenced 
by an unidirectional influx of sodium or efflux of H+. Thus the membrane of 
haloalkaliphiles should per se not be permeable for Na+ and H+ (van de Vossenberg 
et al., 1999). 
1.1.4.3.1.1. Properties of alkaliphilic proteins  
Microorganisms do not only have proteins and enzymes inside the cell, but also 
enzymes that are secreted to the extracellular medium. These proteins have to be 
stable at a high pH in the case of alkaliphiles but also at a high salinity as it is the 
case for haloalkaliphiles. Neutrophile proteins usually denature when the pH is 
raised to a certain extent (Shirai et al., 2008). Thus these proteins exhibit a 
number of interesting modifications in order to maintain functionality under these 
extreme conditions. The mechanisms involved in high pH stability of alkaliphilic 
proteins can be currently categorized into three different strategies: (a) the pKa 
modulation strategy, (b) the Asp+Glu gain (+DE) strategy and (c) the Asp+Lys loss 
– Glu+Arg gain (-DK+ER) strategy (Shirai et al., 2008). 
a) The pKa modulation strategy 
The catalytic activity of an enzyme at a certain pH is highly dependent on 
the pKa values of its catalytic residues. When the surrounding media 
exhibit (highly) alkaline conditions, modifying the pKa value towards a 
higher pH provides a possible solution (Shirai et al., 2008). This is done by 
either modulation of the hydrophobic bonds, shielding catalytic residues 
from the solvent, or changing of the net charge of the molecule. (i) Hydrogen 
bond formation with a catalytic site often (but not always) results in 
lowering the pH optimum for an enzyme, since hydrogen bonds favor the 
deprotonated conformation of certain catalytic residues thus lowering the 
pKa. Therefore modification of the pKa towards a higher pH optimum often 
is achieved by the use of different amino acids (if compared to mesophilic 
homologues) in the proximity of the catalytic residues in order to avoid 
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formation of hydrogen bonds (Shirai et al., 2008). (ii) To function properly in 
an alkaline environment it is also vital to keep the catalytic residues 
protonated, as the proton density is relatively low at high pH values. Amino 
acid residues with large side chains, though are capable of shielding the 
catalytic residues from the solvent molecules surrounding the protein 
(Shirai et al., 2008). (iii) Negatively charged amino acid residues (like Asp 
and Glu) can attract protons thus raising the pKa of ionizable groups and 
resulting in considerably raising the pH optimum of the enzyme (Shirai et 
al., 2008). 
 
b) The Asp+Glu gain (+DE) strategy 
It has been shown that alkaliphilic proteins exhibit a higher aspartic acid 
(Asp, D) and Glutamic Acid (Glu, D) over Arginine (Arg, R) and Lysine (Lys, 
K) ratio (Shirai et al., 2008). This alters the net charge of alkaliphilic 
proteins towards negative values and goes along with the pKa modulation 
theory (see a). In reminiscence to the alkaliphile cell walls, where acidic 
polymers provide negative charges on the surface, proteins are suggested to 
do so by exposing negatively charged amino acid residues thus repelling 
hydroxyl ions (Shirai et al., 2008).  
In addition to that this strategy seems to be similar to the adaptation of 
proteins to high salt conditions and therefore accounts for both alkaliphilic 
and halophilic proteins (Shirai et al., 2008).  
 
c) The Asp+Lys loss – Glu+Arg gain (-DK+ER) strategy 
Two analyses found the basics of this strategy. Together with a crystal 
structure analysis, a ancestral sequence evolutionary trace (ASET) analysis 
of the adaptation process of several proteins, like the alkaline α-amylase 
AmyK or the alkaline cellulose CelK was done (Shirai et al., 2008). By the 
ASET analysis the amino acid residue changes of alkaline proteins were 
compared to their calculated ancestral sequence. In summery it was found 
that during evolution alkaliphilic proteins underwent an alteration in their 
amino acid composition pointing at decreases in the number of Lys and Asp 
residues, while the number of Arg, His and Glu increased (Shirai et al., 
2008). This was confirmed in a second analysis, where differences in the 
structure of alkaline enzymes were compared to those of (recent) non-
alkaline enzymes and assessed with a student´s t-value. In addition to that 
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it could be shown, that the numbers of Lys-Asp/Glu ion pairs decreased, 
while that of Arg-Glu increased (Shirai et al., 2008). Both analyses, the 
ASET, as well as the student´s t-value test led to the conclusion, that ion 
pair remodeling in the above described manner was necessary for alkaline 
adaptation and might be important for protein stability under alkaline 
conditions (Shirai et al., 2008). 
1.1.5. Benefits of doing research with (haloalkaliphilic) Archaea 
In general extremophilic microorganisms, especially the relatively less explored 
Archaea, bury great potential of biotechnological applications let alone the 
potential of elucidating profound evolutional questions, thereby contributing to 
help satisfying man´s desire to explain how humanity itself evolved. 
As the diversity of extremophiles is high, comprising thermophiles, psychrophiles, 
acidophiles, alkaliphiles, halophiles, barophiles and others, the range of 
biotechnological applications is wide as well, considering the large variety of 
different “extremozymes” (Eichler, 2001), that have been discovered in 
extremophiles, as well as considering the various types of enzymes that have not 
yet been discovered. 
A common example of the use of halophilic enzymes is bacteriorhodopsin, which is 
responsible for the reddish color of many members of the Halobacteriacae, where it 
mediates photosynthesis. It has found its way into several light sensitive or 
bioelectrical applications, one of which being holography (Oesterhelt et al., 1991; 
Eichler, 2001). Halophilic biopolymers also are valuable for industrial purposes. 
Biosurfactants that can be produced under high saline conditions could prove 
invaluable for the remediation of oil contaminated soil and water. Since many 
petroleum reservoirs exhibit high salinity, exopolysaccharides from halophilic 
Archaea (such as Halobacterium salinarium, Haloferax volcanii and Halobacterium 
distributum) could be applied in microbial enhanced oil recovery, as emulsifiers 
and mobility controllers (Margesin & Schinner, 2001).  Because of their distinct 
lipid composition liposomes of Haloarchaea could contribute to medical and 
cosmetic applications. There liposomes are utilized as vessels for the transport of 
certain active agents to specific target sites in the body. The unique ether linked 
lipids of Haloarchaea (e.g. Halobacterium cutirubrum) exhibit a higher stability 
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and are far more resistant to esterases than their mesophilic ester linked 
counterparts (Margesin & Schinner, 2001). Other important products of 
Haloarchaea may be polyhydroxyalkanoates (PHA), some of which exhibiting 
similar properties as polyethylene and polypropylene, while being biodegradable at 
the same time. One example is Haloferax mediterranei that produces large 
quantities of poly β-hydroxy butyric acid (PHB). In addition to that the extraction 
of PHB is very easy, since haloarchaeal cells simply lyse when the salt 
concentration is lowered to a certain point (Rodriguez-Valera & Lillo, 1992; 
Margesin & Schinner, 2001; Ventosa & Nieto, 1995). Furthermore enzymes that 
work under highly alkaline conditions are very important for industry. Alkaline 
proteases are mainly used as detergent additives, as well as in hide – dehairing 
processes (Horikoshi, 1999). From a biotechnological point of view haloalkaliphilic 
Archaea constitute an important group of microorganisms, as their proteins and 
enzymes combine halophilic and alkaliphilic features, both being valuable for 
industrial purposes.  
However, the benefit of studying extremophiles lies not only in the finding of new 
applications for their products and enzymes but also has it greatly contributed to 
our understanding of protein folding, stability, structure and function (Gomes & 
Steiner, 2004).  
1.1.6. Natrialba magadii 
The archaeon Natrialba magadii was initially described as Natronobacterium 
magadii by Tindall et. al. in 1984 (Tindall et al., 1984) where it was isolated from 
Lake Magadi (Kenya), which belongs to the east African Rift valley lakes and 
provides a high saline as well as a high alkaline environment thus being suitable 
for haloalkaliphilic microorganisms. Originally the discovered microbes where put 
into two generas – the rod shaped Natronobacteria and the cocci shaped 
Natronococci (Tindall et al., 1984). However, in 1997 a 16S and 23S rRNA analysis 
performed by Kamekura et al. led to the introduction of new genera, one of which 
being the genus Natrialba, where Natronobacterium magadii was transferred to 
and since then is classified as Natrialba magadii (Kamekura et al., 1997). 
Nab. magadii belongs to the kingdom Euryarchaeota and as an alkaliphilic 
member of the family Halobacteriaceae, it requires a high sodium chloride 
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concentration, a high pH, as well as low Mg2+ concentrations (below 10 mM) 
(Kamekura et al., 1997). The cells are motile and have an orange to red color, due 
to carotenoids stored in their membrane. Nab. magadii exhibits a rod shaped 
morphology, the cells measuring 5 – 7 µm in length and grows aerobically. It exerts 
optimal growth at a temperature from 37° C – 42° C, a pH of 8.5 – 10.5 and a 
sodium chloride concentration of 4 M. In order to prevent cell lysis, a minimum of 
2 M NaCl is required (Tindall et al., 1984). But even under optimal conditions 
growth of Nab. magadii in comparison to E. coli is very slow. The equivalent to an 
E. coli over night liquid culture can easily take up to seven days, and streaks on 
plates containing Nab. magadii rich medium can take even longer to show colonies. 
Incubation for 14 days or longer is no exception.  
1.1.6.1. Nab. magadii in the laboratory 
In our laboratory currently two strains of Nab. magadii are available – the wt L11 
strain, containing the lysogenic halovirus φCh1 (see chapter 1.2.2.) and the cured 
strain L13, which does no longer contain the virus. Nab. magadii L13 has been 
obtained by repeated subculturing and testing of colonies by infection with φCh1 
(Witte et al., 1997). L13 serves as an indicator strain, as it can be infected with 
φCh1, in contrast to L11, where a super infection is impossible.  
We are also able to transform Nab. magadii with a shuttle vector that has been 
developed in this laboratory (Iro et al., in prep.).  
 
a b 
Figure 2| Morphology of Nab. magadii. Electron micrographs showing Nab. magadii cells. 
Belonging to the family of Halobacteriacae Nab. magadii was  originally isolated from Lake 
Magadi (Kenya), a soda lake situated along the North African Rift valley where it faces both a 
high saline as well as a high alkaline environment. For optimal growth a sodium chloride 
concentration of 4 M, as well as a pH of 9.5 – 11 is required. a|The wild type strain L11 carries 
φCh1 as a prophage. b| The strain L13 has been cured of the phage and serves as indicator 
strain since it can be infected with φCh1.   
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1.1.6.1.1. Transformation of Nab. magadii 
The first reported event of the transformation (transfection) of an archaeon dates 
back to 1987 where Cline and Doolittle managed to transfect Halobacterium 
halobium∗ with DNA obtained from the phage φH. The success of their method was 
measured by performing plaque assays. The method is based on the removal of the 
S-layer by EDTA, a chelating agent, in the absence of Mg2+ resulting in the 
formation of round shaped spheroblasts. These can be subsequently transformed 
with DNA with the aid of polyethylene glycol (PEG 600) (Cline & Doolittle, 1987; 
Charlebois et al., 1987). The principles for transformation of Haloarchaea that were 
discovered then are still valid today. To the present day several other Haloarchaea 
could be transformed with DNA and the current knowledge in doing so is presently 
thoroughly collected in Michael L. Dyall-Smith´s manuscript “The Halohandbook” 
(Dyall-Smith, 2008), a compilation of various methods for working with 
Haloarchaea. However, for the transformation of Nab. magadii some alterations to 
the standard protocols had to be made. As EDTA has no effect on Nab. magadii´s 
S-layer our protocol involves the growth of the cells in media containing bacitracin, 
in order to weaken the glycolysation of the S-layer glycoproteins, subsequently 
followed by an enzymatic digest mediated by Tritirachium album proteinase K 
(Moens & Vanderleyden, 1997; Mescher & Strominger, 1976). After this treatment 
the resulting spheroblasts can be transformed according to standard protocols (for 
detailed information of the transformation protocol see chapter 2.2.2.) (Iro et al., in 
prep.).   
1.1.6.1.2. Genetic markers in Nab. magadii 
Back in 1987 when Cline and Doolittle started doing transformation of 
Haloarchaea their work was exacerbated by lack of genetic loci that would work as 
selectable markers.  Today, although the list of antibiotics affecting Archaea is still 
not very long, in our laboratory we take advantage of two genetic markers, one of 
which being a novobiocin resistance, the other being a mevinolin resistance. 
Novobiocin inhibits DNA gyrase in Bacteria, by binding to the gyrB subunit 
thereby preventing binding of ATP which results in a strong growth inhibitory 
effect (Holmes & Dyall-Smith, 1991). It has been shown that novobiocin also 
targets DNA gyrase of Haloarchaea and that resistance to this antibiotic in 
                                                
∗ later termed Halobacterium salinarium (Ventosa & Oren, 1996) 
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Haloferax sp. is due to three point mutations in the gyrB homologue, all of which 
possibly affecting the region of the ATP binding site (Holmes & Dyall-Smith, 1991). 
Mevinolin inhibits the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) 
reductase, which in eukaryotes and Archaea is participated in the synthesis of 
mevalonic acid from coenzyme-A (Lam & Doolittle, 1992). Mevalonate in Archaea is 
used for the production of isoprenoid side chains for their unique lipids. Two 
different events independently lead to mevinolin resistance, being either the 
introduction of a tandem repeat of the HMG-CoA gene or a point mutation 
upstream of the gene, resulting in an up-regulation, and thereby producing an 
excess of the HMG-CoA gene product (Lam & Doolittle, 1992).  
1.2. Viruses of the Archaea 
In the context of Archaea both terms “virus” and “phage” are used synonymously. 
The term “virus” is derived from the Latin word for toxin or poison whereas 
“phage” is Greek for eating.  In a microbial context “phage”, simply is an 
abbreviation for “bacteriophage” (“bacterium eater”), which after the findings of 
Woese et al. could no longer be used as a valid term with respect to Archaea. 
However, many archaeal viruses have been discovered before the domain Archaea 
was split from the Bacteria and thus have been called “phages”, though nowadays 
the term “virus” would scientifically be more correct. 
1.2.1. Diversity of archaeal viruses 
The first archaeviruses to be discovered were viruses infecting Halobacterium 
salinarium and Halobacterium cutirubrum, respectively (Torsvik T, 1974; Wais et 
al., 1975). They were reminiscent to the bacteriophages of the family Myoviridae. 
Later viruses resembling phages of the family Siphoviridae were found, leading to 
the sophism of archaeviruses being just a variety of the common head tail type 
morphology bacteriophages (Prangishvili et al., 2006a). This view however changed 
dramatically since the early days of the discovery of archaeviruses. Though, until 
now all of the described viruses of the Archaea contain linear or circular dsDNA, 
they exhibit an overwhelming morphological diversity with unique morphotypes 
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that are currently unknown for eukaryal viruses, as well as bacteriophages 
(Prangishvili et al., 2006a). The viruses of the crenarchaeal Sulfolobus 
neozealandicus and Acidianus gen. display so exceptional shapes that upon 
discovery they were assigned to two totally new families. While the Acidianus 
bottle shaped virus (ABV) and the Sulfolobus neozealandicus droplet shaped virus 
(SNDV) constitute members of the family Ampullaviridae, the Acidianus two-tailed 
virus (ATV) was assigned to the family Guttaviridae (Prangishvili et al., 2006a). 
Among the main archaeal kingdoms of the Euryarchaeota and the Crenarchaeota 
the morphologies of the viruses differ dramatically, with only two types of virions 
occurring in both kingdoms: (i) spindle-shaped, enveloped virions with a short tail 
at one pointed end and (ii) spherical, lipid-containing virions with layered shell 
appearance and no discernible tail (Prangishvili et al., 2006a; Prangishvili et al., 
2006b). Otherwise both kingdoms differ greatly, with the kingdom of the 
Euryarchaeota currently displaying mostly tailed dsDNA viruses (Prangishvili et 
al., 2006b). So far head tail viruses in Archaea have only been found to exclusively 
infect extreme halophiles or methanogens. Among these are the closely related 
Halobacterium salinarium virus φH and Nab. magadii virus φCh1, both of which 
being reminiscent of bacteriophages in their genome content, as well as in 
containing mosaic genomes due to extensive genetic exchange during the course of 
evolution (Prangishvili, Forterre and Garrett, 2006a).  
1.2.1.1. Haloviruses 
The first haloviruses found happened also to be the first archaeal viruses ever to be 
described (Torsvik T, 1974; Wais et al., 1975). Given the numerous species of 
Haloarchaea that have been discovered since then, the number of described 
haloviruses is surprisingly low, also with respect to the fact, that the viral titer of 
hypersaline environments can be as high as 107 pfu/ml. Halobacterium salinarium 
virus φH currently is probably the best described halovirus and like many of the 
euryarchaeal viruses it exhibits a head-tail morphology (Dyall-Smith et al., 2003). 
After discovery by Torsvik et al. in 1974 the lab of Wolfram Zillig at the Max-
Planck Institute in Munich was mostly responsible for elucidating the 
characteristics of φH being a temperate virus possessing a genome size of 58.9 kbp 
of dsDNA and except from some methylase genes showing little sequence 
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similarities with known bacteriophages, though replication as well as control of 
lysogeny resemble the P1 bacteriophage (Schnabel et al., 1982; Dyall-Smith et al., 
2003). 
In 1993 Nuttal and Dyall-Smith at the University of Melbourne, Australia 
described two new head-tail viruses, HF1 and HF2. They showed identical 
morphologies and about 80 % genomic identity, but surprisingly had a completely 
separate host range, although isolated from the same lake, both being able to infect 
more than one host and both viruses being lytic (Nuttall & Dyall-Smith, 1993; 
Dyall-Smith et al., 2003). This led to the question, whether temperate phages like 
φH and the very closely related φCh1 really are the dominant form of viruses 
among the Haloarchaea. Furthermore Bath and Dyall-Smith discovered two more 
lytic viruses, one of which being the Haloarcula hispanica infecting phage His1, 
similar in shape to the fusiform SSV1 virus particle of Sulfolobus solfataricus. The 
other one, His2, also using Haloarcula hispanica as a host, though did not show a 
morphological resemblance of SSV1. However, on a molecular level both His1 and 
His2 differ fundamentally from SSV1. The latter one being a temperate virus, 
exhibiting a circular genome, whereas His1 and His2 are lytic, display a linear 
genome and have their own DNA polymerase (Bath & Dyall-Smith, 1998; Bath et 
al., 2006; Dyall-Smith et al., 2003). In addition to that after the analysis of Dead 
Sea water by Oren et al. in 1997 the perception began to emerge, that head-tail 
viruses as well might not even be the most abundant archaeviral morphotypes 
(Oren et al., 1997; Dyall-Smith et al., 2003).  
Though since the description of the first haloviruses major advances on this field of 
research have been made, the number of described haloarchaeal viruses is still 
relatively low. In their 2003 paper on haloviral diversity Dyall-Smith, Tang and 
Bath spot the major reason for this fact in the lack of cultivable hosts that are the 
dominant microorganism in their respective environment. Thus being able to 
cultivate the dominant microorganisms in high saline environments will ultimately 
lead also to the identification of novel, as well as dominant haloarchaeal virus 
species (Dyall-Smith et al., 2003). 
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1.2.2. The Halovirus φCh1 – a general view 
In 1997 the first phage ever detected to infect a haloalkaliphilic archaeon was 
φCh1 (Witte et al., 1997). It is a temperate phage and infects Nab. magadii, an 
archaeon belonging to the kingdom Euryarchaeota, requiring both high salinity 
and an alkaline pH. φCh1 was discovered upon spontaneous cell lysis of Nab. 
magadii batch cultures. Lysis only occurred after cultures were grown to stationary 
phase, suggesting a growth phase dependent lysis behavior (Witte et al., 1997). The 
virus causes turbid plaques when infected cells are plated upon a cell lawn. Phages 
were isolated from a single colony obtained from the edge of a plaque that 
contained vital cells which just then had not lysed. These cells were given the name 
“L11” and were used for all subsequent isolations of φCh1 (Witte et al., 1997). 
However, superinfection of Nab. magadii host cells with the virus is not possible, 
as is known for other (bacterio-) phages like the E. coli λ phage or φH of 
Halobacterium salinarium (Witte et al., 1997; Stolt & Zillig, 1992). Thus, a second 
Nab. magadii strain was isolated, by repeated subculturing and searching for 
altered lysis behavior. In this manner, a strain could be isolated, which had been 
cured of φCh1 and would serve as indicator strain, as it could be infected with the 
virus. This strain was termed Nab. magadii L13 (Witte et al., 1997).  
1.2.2.1. Morphology of φCh1 
φCh1 exhibits a morphology typical for head-tail phages of the family Myoviridae, 
resembling E. coli T4 phage or φCh1 close relative φH of Halobacterium 
salinarium. The overall length of the phages lies around 200 nm, with 
icosahedrical heads approx. 70 nm and tails approx. 130 nm in length . The tail has 
an internal shaft covered by the contractible tail, exhibiting a total width of about 
20 nm (Witte et al., 1997). Electron micrographs show structures on the end of the 
tails, which are likely to be responsible for phage adsorption to the host cell (see 
Fig. 3a). Sodium chloride concentrations lower than 2 M result in the loss of 
infectivity, suggesting either phage disassembly under these conditions or 
significant conformational changes of structures participating in phage adsorption. 
Thus φCh1 seems to be perfectly adapted to the haloalkaline conditions its only 
known host, Nab. magadii, requires (Witte et al., 1997). 
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1.2.2.2. Protein composition of φCh1 particles 
Early analysis of the virus revealed, that it consists of nine proteins termed A – I, 
respectively. Concerning the quantity by which they occur in the mature virus 
there are four major (A, E, H, I) and five minor (B, C, D, F, G) proteins (Witte et al., 
1997). Protein E has been shown to be the major capsid protein of φCh1. It is 
expressed in the late phase of virus development and during virus maturation 
undergoes proteolytic cleavage within the host Nab. magadii (Klein et al., 2000). 
The majority of these nine proteins is acidic and displays isoelectric points between 
pH 3.3 and pH 5.2 thus rendering these proteins typical for halophiles (Witte et al., 
1997). 
1.2.2.3. φCh1 is a temperate phage 
Within the host cell temperate phages can have two distinct forms of existence. 
Phage DNA can either exist as an episomal element being ready for the lytic phage 
cycle, or it can integrate into the bacterial/archaeal chromosome where it is 
preserved and propagated together with the cellular DNA via cell division. 
Figure 3| Morphology of φCh1 particles. a| The electron micrograph of a φCh1 virus 
particle shows a head tail morphology that is typical for the Myoviridae. At the bottom of the 
phage tail fibers are visible. (Photo kindly provided by Elke Bogner, Charite’ Berlin, Institut 
für Virologie) b|Schematic representation of the virus particles (Witte et al., 1997). 
a b 
50 nm 
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The fact that φCh1 lyses Nab. magadii only after it has been grown to stationary 
phase already suggests a lysogenic state of the virus. By hybridization of phage 
DNA with Nab. magadii L11 DNA the location where φCh1 is integrated into the 
chromosome could be determined (Witte et al., 1997). It could also be shown, that 
extrachromosomal phage DNA does not show up until one day before onset of lysis.  
Furthermore, as assumed, no hybridization occurred when DNA from the non 
lysogenic Natrialba magadii L13 was used, thus proving that L13 indeed is cured 
from the phage (Witte et al., 1997).  
1.2.2.4. Genetic organization of φCh1 
The genome of φCh1 consists of linear dsDNA. It has been sequenced in 2002 by 
Klein et al. and has a size of 58498 bp. Furthermore it was shown to be circularly 
permuted and terminally redundant, a feature that φCh1 shares with a number of 
bacteriophages (Klein et al., 2002). By restriction analysis it could also be shown 
that aside from the linear form in the mature viral capsid, the viral DNA also must 
have a circular replicative form inside the host cell and that packaging of DNA 
occurs via the well known “head-full” mechanism, which explains the terminal 
redundance (Klein et al., 2002). Prior to sequencing high pressure liquid 
chromatography (HPLC) was performed and revealed a G+C content of approx. 
62 % (Witte et al., 1997). Interestingly, in addition to that mature φCh1 particles 
also contain RNA. In a series of hybridization experiments this RNA was shown to 
be host derived, i.e. encoded by Nab. magadii chromosomal DNA. The DNA to RNA 
ratio is about 1:5 and at least eight different species of φCh1 packaged RNA have 
been identified, all of which ranging in the size of 5S rRNA. However, their 
function is still unknown (Witte et al., 1997). Participation in the packaging process 
of DNA into the phage particles, like for example the eubacterial phage φ29 (Guo et 
al., 1987a; Guo et al., 1987b), remains a possibility. However, while φ29 RNA has 
been shown to be associated with the prohead of the phage particle and thus is 
susceptible to RNAse treatment (Guo et al., 1987a; Guo et al., 1987b), RNA of 
φCh1, being protected by the mature capsid, is totally unaffected by such a 
treatment (Witte et al., 1997). 
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Another interesting fact is that φCh1 DNA is partially methylated (Witte et al., 
1997). Restriction analyses with isoschizomeric enzymes Sau3A, DpnI, MboI, 
respectively revealed a Dam-like adenine methylation of the cognate restriction 
site (5´-GATC-3´), as is known for Enterobacteriaceae. These three enzymes are 
either completely unaffected by adenine methylation (Sau3A), dependent on this 
methylation (DpnI) or inhibited by it (MboI).  It is also apparent that this Dam-like 
modification occurs on both strands as DpnI and MboI only digest Dam sites if they 
are methylated or non-methylated on both strands, respectively (Witte et al., 1997).   
On the other hand modification of cytosine residues could not be observed, upon 
cleavage with enzymes corresponding to cytosine methylation. Furthermore, 
restriction analyses clearly show that only a fraction of φCh1 DNA is methylated, 
whereas the rest remains unmodified. However, if methylated, this affects the 
whole genome, as there were no intermediate DNA fragments observed after 
restriction analysis (Witte et al., 1997). After all Dam-like methylation of φCh1 
Figure 4| Genetic organization of virus φCh1. Sequencing the 58498 bp genome by Klein 
et al. in 2002 revealed a total of 98 predicted open reading frames (if the minimum length for 
an ORF was considered to be at least 30 codons). The genome shows a modular organization 
with the left part coding for structural components and assembly, the central part coding for 
genes important for DNA replication and the right part containing genes responsible for DNA 
modification.  
(Klein et al., 2002; with modifications) 
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DNA is rather surprising, given that such a modification in the DNA of the host, 
Nab. magadii is not observed (Lodwick et al., 1986). Thus it was suspected that 
either φCh1 encodes for its own methyltransferase (Mtase), or that an otherwise 
silent host encoded Mtase is activated during virus maturation (Witte et al., 1997). 
The former was confirmed when a virus encoded Mtase homolog could be 
identified, that is expressed in the late phase of virus development, and thus only a 
small fraction of viral DNA is becoming methylated, since packaging of DNA then 
is already in progress (Baranyi et al., 2000). Yet, the purpose of φCh1 DNA 
methylation is still unclear. One option is that it represents an adaptation to a 
restriction/modification system of a so far unknown host (Baranyi et al., 2000). 
As mentioned above, the φCh1 genome has already been sequenced. A total of 98 
predicted open reading frames (ORFs) could be identified, when ATG and GTG 
were considered as start codons and an ORF length of at least 30 codons was 
assumed (see Figure 4). However, only four of the predicted ORFs were found to 
actually start with a GTG. The tight arrangement of many ORFs pointing in the 
same direction over large areas of the genome indicates an organization into 
transcriptional units (Klein et al., 2002).  Comparison to available sequences in 
databases and to the only partially sequenced close relative φH gives a total of 48 
matches, with only 17 matching to proteins with known functions and 31 matching 
to conserved hypothetical proteins of unknown function. However, the majority of 
the latter show high similarities to Halobacterium salinarium virus φH, only 
(Klein et al., 2002). The φCh1 genome is organized into three major parts: (i) the 
left part, harboring genes mainly responsible for structural proteins and virion 
morphogenesis, (ii) the central part, where genes for replication, plasmid 
stabilization and gene regulation are situated and (iii) the right part with most 
genes of currently unknown functions in addition to genes involved in methylation 
and restriction (Klein et al., 2002). The central part strikingly resembles the L-part 
of φH, which can circularize and replicate as an autonomous plasmid (Gropp et al., 
1992). The two fragments share sequence identities between 50 – 97 %. This is 
surprising, since the host range of φCh1 and φH is completely different with hosts 
that do not even belong to the same genus (Klein et al., 2002). This segmented 
composition could be the result of the acquisition, i.e. exchange, of such modules 
among head tail viruses beyond the three domains during the course of evolution. 
Such a mechanism could be the main driving force of viral evolution. It explains 
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the similarities that φCh1 shares not only with φH but also with other 
bacteriophages (Hendrix et al., 2000). 
Sequencing also revealed another interesting feature in the φCh1 genome. It also 
encodes for two site specific recombinases (int1 and int2) of the λ-integrase type 
(Klein et al., 2002). Int1, encoded by ORF35 could be shown to be participated in 
the inversion of the neighboring ORFs 34 and 36, respectively (Rössler et al., 2004). 
The gene products of these two ORFs are likely to be part of the mature virus 
particle, as they are both detectable in an α-φCh1 antiserum. The inversion reaction 
produces a rearrangement of the C-terminal ends of both ORFs among each other, 
thereby possibly resulting in a structural change of the mature virus particle 
(Rössler et al., 2004). As is known for bacteriophages Mu and P1 (Iida, 1984; 
Sandmeier, 1994) this could eventually lead to a shift in the host specificity, though 
to this date no hosts other than Nab. magadii have been found (Rössler et al., 
2004).  
1.2.2.5. The φCh1 replication region and development of a shuttle 
vector 
Sequencing of the φCh1 genome revealed homologies to a gene called repH. RepH 
as well as an AT-rich region 5´ to the gene were shown to be required for the 
replication of plasmids in halophilic Archaea (Ng & DasSarma, 1993). However, in 
φCh1 two ORFs, show a remarkable similarity to repH of Haloarcula marismortui 
plasmid pNRC100. (i) ORF54 contains GTG as a start-codon and encodes a protein 
of 581 amino acids in length, weighing approx. 65 kDa.  This protein possibly 
contains a coiled coil structure in its center and the highest similarities to RepH 
were found to be located in the C-terminal end. (ii) ORF53 which lies upstream of 
ORF54 has a lower, yet significant homology to repH than ORF54. However, it 
resembles RepH only with its N-terminal end. In addition to that, an AT-rich 
region lies upstream of ORF53 and another one downstream of ORF54. These facts 
suggest that the φCh1 origin of replication is comprised of two rather than one 
open reading frames (Klein et al., 2002; Iro et al., in prep.).  
In order to further investigate the origin of replication of φCh1, as well as to 
construct a functional vector system for haloalkaliphilic Archaea, the above 
described region was used to develop a shuttle vector for E. coli and Nab. magadii. 
The basis for this system was provided by a pKSII+ vector. Onto this plasmid the 
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mutated gyrB gene of Haloferax alicantei (Holmes & Dyall-Smith, 1990), which 
confers novobiocin resistance, was cloned. The resulting vector, pNov-1, was used 
for a cloning series during which different fragments of the putative φCh1 origin of 
replication were analyzed (Iro et al., in prep.). This was done by determining the 
transformation efficiency of Nab. magadii with pNov-1 plasmids containing the 
respective fragments. These vectors were termed “pRo” and given a number (see 
Figure 6) (Iro et al., in prep.). Plasmids pRo-1 and pRo-2, which lack the promoter 
in front of ORF49 as well as the 5´ AT-rich region, did not give any transformants. 
Plasmid pRo-4, containing the whole φCh1 replication region as depicted in Figure 
6, gave very low transformation efficiencies. Only pRo-3, pRo-5 and pRo-6 could be 
transformed with significant efficiencies with pRo-5 performing slightly better. The 
latter no longer contains the start codons of two ORFs suspected to be involved in 
transcriptional repression of φCh1 – ORF49 and ORF55. (Iro et al. in prep).  
The present work also participates in the investigation of the φCh1 replication 
region, as it remained to be proved, whether ORF53 or ORF54 are both necessary 
for replication. In addition to that the role of the ORF53/54 5´ and 3´ palindromic 
flanking regions is further characterized. These regions constitute putative binding 
sites for the gene products (gp) of ORF53 or ORF54, respectively and as stated 
above such interactions have been reported for repH by Ng and DaSarma (Ng & 
DasSarma, 1993).   However, for φCh1 their role is still not fully elucidated as well.  
1.2.2.6. Gene regulation in φCh1 
The φCh1 genome contains two putative repressor genes, ORF48 and ORF49, 
respectively. ORF48 shows significant sequence similarities to the known repressor 
of the φCh1 close relative φH (Klein et al., 2002). It contains an amino acid pair, 
Ala73-Gly74, which is also known to be conserved in repressors of various other 
bacteriophages (Raymond-Denise & Guillen, 1991; Perry et al., 1985; Iro et al., 
2007). For these reasons ORF48 was named rep. It belongs to the winged helix-
turn-helix DNA binding proteins, a family where the loops are small beta sheets. 
However, in contrast to many other known repressors rep was shown to be 
constitutively expressed during the virus maturation, suggesting an additional 
mechanism for φCh1 gene regulation (Iro et al., 2007). 
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The repressor function of the gene product of ORF49 (gp49) was suspected after the 
analysis of the lysis behavior of several φCh1 infected Nab. magadii cultures 
derived from single plaques. One virus variant, termed φCh1-1, showed an increase 
in plaque formation as well as an earlier onset of lysis. 
 
Sequence analysis revealed that φCh1-1 carries a duplicated 223 bp fragment 
comprising a part of ORF49 and a few nucleotides of its upstream region (nu. 
34371–34593) (Iro et al., 2007; see also Figure 5). This duplication produces an 
additional open reading frame, ORF49´, which lies just in front of the original 
b 
Figure 5| Gene regulation in φCh1 by ORF48 (rep) and ORF49. Studying the lysis 
behavior of φCh1 infected Nab. magadii cells obtained from different plaques revealed a virus 
variation that showed an earlier onset of lysis. It was termed φCh1-1. a| Growth curves of 
different Nab. magadii cultures infected with φCh1 wt ( ○ ) and φCh1-1 ( ● ). b| Sequence 
analysis of φCh1-1 revealed a duplication of a 223 bp fragment resulting in an additional open 
reading frame – ORF49´ in front of the original ORF49 with a few overlapping nucleotides. 
c| RT-PCR showing that while ORF48 (rep) is constitutively expressed during the φCh1 life 
cycle expression of ORF49 starts in the logarithmic growth phase of the cells and increases 
during virus development.  
(a, c: Iro et al. 2007; b: personal communication) 
a c 
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ORF49 with only a few overlapping nucleotides. Thus a co-transcription and 
-translation of both ORF49 and ORF49´ seems to be likely. The importance of 
ORF49 for the φCh1 life cycle is also underlined by the fact, that the mutation that 
leads to ORF49´ is not stable and reverts into the wild type relatively quickly (Iro 
et al., 2007).  
In contrast to ORF48, ORF49 is not constitutively expressed. ORF49 expression 
starts in the logarithmic phase and increases during virus development (Iro et al., 
2007). However, the mechanism that triggers its expression is so far unknown. 
Both, rep and ORF49 are situated head to head on the φCh1 genome with their 
intergenic region containing promoter consensus sequences. Reporter gene assays 
showed that ORF48 is responsible for a dramatic decrease of bgaH activity, when 
bgaH is transcribed from the ORF49 promoter (Iro et al., 2007). This indicates the 
role of Rep as a transcriptional repressor. The fact, that rep is expressed 
constitutively while ORF49 is not points at other factors involved in the regulation 
of the ORF48/ORF49 system, where the expression of ORF48 has to be overcome at 
a certain point in time to allow for ORF49 to be expressed (Iro et al., 2007).  
The present work contributes in the further elucidation of the role of ORF49 in the 
regulation of the φCh1 life cycle and the characterization of the activity of the 
repressor. 
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2. Materials & Methods 
2.1. Materials 
2.1.1. Strains 
2.1.1.1. Bacterial strains 
Strain Genotype Reference 
E. coli XL-1-Blue endA1, gyrA96, hsdR17 (rk-mK+), lac, 
recA1, relA1, supE44, thi, (F´, lacIq, 
lacZDM15, proAB+, tet) 
 
Stratagene 
E. coli BL21(DE3) pLysE 
 
F-, ompT, hsdSB (rB-mB-), gal, dcm, 
(DE3), pLysE (CmR) 
 
Novagen 
E. coli Rossetta 
 
F-, ompT, hsdSB (rB-mB-), gal, dcm, 
lacY1, (DE3), pRARE6, (CmR) 
 
Novagen 
E.coli TunerTm 
 
F-, ompT, hsdSB (rB-mB-), gal, dcm, 
lacY1 
 
Novagen 
E. coli C41 pLysS 
 
F-, ompT, hsdSB (rB-mB-), gal, dcm, 
(DE3), pLysS (CmR) 
 
(Miroux & 
Walker, 1996) 
E. coli C43  pLysS 
 
F-, ompT, hsdSB (rB-mB-), gal, dcm, 
(DE3), pLysS (CmR) 
 
(Miroux & 
Walker, 1996) 
E.coli GM48F´ 
 
F-, thr, leu, thi-1, lacY, galK, galT, ara, 
tonA, tsx, dam, dcm, supE44 
 
(Palmer & 
Marinus, 
1994) 
 
  
Materials & Methods 
42 
2.1.1.2. Archaeal strains 
Strain Genotype Reference 
Nab. magadii L11 wt., φCh1 as prophage (Witte et al., 1997) 
Nab. magadii L13 φCh1 cured derivate of 
L11 
(Witte et al., 1997) 
2.1.2. Growth media 
LB and LB + 0.2 % Glucose (rich media for E. coli) 
Peptone  10 g  
Yeast Extract  5 g 
NaCl   5 g 
(Glucose  2 g)* 
pH 7.0 
add dH2O to 1 l 
 
for plates 15 g/l Agar were added 
*LB + 0.2% Glucose was used with cultures containing the pMal-c2X vector 
NVM+ (rich medium for Nab. magadii) 
 Casamino acids  8.8 g 
 Yeast extract   11.7 g 
 Tri-Na citrate   0.8 g 
 KCl    2.35 g 
 NaCl    235 g 
 pH  9.0 
 add dH2O to a final volume of 933 ml 
 8 g/l agar were added for plates 
 4 g/l agar were added for soft agar 
After autoclaving the medium or the agar were complemented by adding the 
following solutions (to obtain 1 l): 
 0.57 M  Na2CO3 (dissolved in sterile dH2O)  65 ml 
 1 M   MgSO4 (autoclaved)    1 ml 
 20 mM FeSO4 (dissolved in sterile dH2O)  1 ml 
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2.1.3. Antibiotics 
2.1.3.1. for E. coli 
Antibiotic Final 
concentration 
General remarks 
ampicilin 100 µg/ml dissolved in sterile ddH2O, sterile 
filtered, stored at +4° C 
 
tetracycline 10 µg/ml dissolved in 70 % EtOH, stored at 
-20° C, light sensitive 
 
chloramphenicol 20 µg/ml dissolved in 96 % EtOH, stored at 
-20° C 
 
2.1.3.2. for Nab. magadii 
Antibiotic Final 
concentration 
General remarks 
novobiocin 3 µg/ml Dissolved in sterile ddH2O, sterile 
filtered, stored at -20° C 
 
bacitracin 70 µg/ml dissolved in sterile ddH2O, sterile 
filtered, stored at +4° C 
2.1.4. Vectors 
Plasmid Features Source 
pUC19 bla, pMB1ori, lacZa, mcs (Yanisch-Perron 
et al., 1985) 
pKSII+ mcs, bla, ColE1 ori, lacZa Stratagene 
pRSETA mcs, bla, EK, PT7, RBS, His-tag, 
pUC ori, f1 ori 
Invitrogen 
 
pRSETC mcs, bla, EK, PT7, RBS, His-tag, 
pUC ori, f1 ori 
Invitrogen 
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pMal-c2X lacIq, Ptac, malE, pMAL-p4X 
polylinker, lacZa, rrnb terminator, 
Ampr, M13 ori, pbr322 ori 
New England 
BioLabs 
 
 
pKSII+ - TR4/Ro6-
TR3/Ro7 
mcs, bla, ColE1 ori, lacZa; carrying 
φCh1 fragments TR4/Ro6 and 
TR3/Ro7  
(Ladurner, 2008) 
pNov-1 bla, ColE1 ori, gyrB (Ladurner, 2008) 
pRo-4 bla, ColE1 ori, gyrB, φCh1 derived 
ori 
(Iro et al., in 
prep.) 
pRo-5 bla, ColE1 ori, gyrB, φCh1 derived 
ori 
(Iro et al., in 
prep.) 
pRo-6 bla, ColE1 ori, gyrB, φCh1 derived 
ori 
(Iro et al., in 
prep.) 
pRo-7 bla, ColE1 ori, gyrB, φCh1 derived 
ori 
this thesis 
 
pRo-8 bla, ColE1 ori, gyrB, φCh1 derived 
ori 
this thesis 
 
pRo-9 bla, ColE1 ori, gyrB, φCh1 derived 
ori 
this thesis 
 
pRo-10 bla, ColE1 ori, gyrB, φCh1 derived 
ori 
this thesis 
 
pRo-11 bla, ColE1 ori, gyrB, φCh1 derived 
ori 
this thesis 
 
pRo-5-ORF49 bla, ColE1 ori, gyrB, φCh1 derived 
ori, φCh1 ORF49 (nu. 34480-34833) 
 
(Meissner, 2008) 
pRo-5-ORF49Δ1 bla, ColE1 ori, gyrB, φCh1 derived 
ori, φCh1 ORF49 Δ1 (nu. 34321-
34795) 
 
this thesis 
pRo-5-ORF49Δ2 bla, ColE1 ori, gyrB, φCh1 derived 
ori, φCh1 ORF49 Δ2 (nu. 34321-
34760) 
 
this thesis 
pRo-5-ORF49Δ3 bla, ColE1 ori, gyrB, φCh1 derived 
ori, φCh1 ORF49 Δ3 (nu. 34321-
34723) 
this thesis 
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pRo-5-ORF49Δ4 bla, ColE1 ori, gyrB, φCh1 derived 
ori, φCh1 ORF49 Δ4 (nu. 34321-
34686) 
this thesis 
pRo-5-ORF49Δ5 bla, ColE1 ori, gyrB, φCh1 derived 
ori, φCh1 ORF49 Δ5 (nu. 34321-
34650) 
 
this thesis 
pMal-c2X-ORF49 lacIq, Ptac, malE, pMAL-p4X 
polylinker, lacZa, rrnb terminator, 
Ampr, M13 ori, pBR322 ori, φCh1 
ORF49 (nu. 34480-34833) 
 
this thesis 
pRSETA-ORF49 mcs, bla, EK, PT7, RBS, His-tag, 
pUC ori, f1 ori, φCh1 ORF49 (nu. 
34480-34833) 
 
this thesis 
pRSETA-ORF49Δ1 mcs, bla, EK, PT7, RBS, His-tag, 
pUC ori, f1 ori, φCh1 ORF49Δ1 (nu. 
34480-34795) 
this thesis 
pRSETA-ORF49Δ2 mcs, bla, EK, PT7, RBS, His-tag, 
pUC ori, f1 ori, φCh1 ORF49Δ2 (nu. 
34480-34760) 
this thesis 
pRSETA-ORF49Δ3 mcs, bla, EK, PT7, RBS, His-tag, 
pUC ori, f1 ori, φCh1 ORF49Δ3 (nu. 
34480-34723) 
this thesis 
pRSETA-ORF49Δ4 mcs, bla, EK, PT7, RBS, His-tag, 
pUC ori, f1 ori, φCh1 ORF49Δ4 (nu. 
34480-34686) 
this thesis 
pRSETA-ORF49Δ5 mcs, bla, EK, PT7, RBS, His-tag, 
pUC ori, f1 ori, φCh1 ORF49Δ5 (nu. 
34480-34650)  
this thesis 
pRSETA-ORF49ΔN mcs, bla, EK, PT7, RBS, His-tag, 
pUC ori, f1 ori, φCh1 ORF49ΔN (nu. 
34636-34833) 
this thesis 
pKSII+ promoter 43 + 
ORF44 / 3 
mcs, bla, ColE1 ori, lacZa, PORF43, 
ORF44 of φCh1 
(Iro et al., 2007) 
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2.1.5. Primer 
Name Sequence Restriction 
site 
TR-1 AATTGCGGCCGCCGCGTTGAAGGCA NotI 
TR-2 AATTTCTAGATCCTGGGCCTCTTTGAA XbaI 
TR-31 AATTTCTAGACCATCGTGATAACGTTTGCG XbaI 
Ro-7 AATTCCCGGGGGCCGTG SmaI 
TR-4 GCAGAAGCTTCGGCGTGATCGCGAGTAA HindIII 
Δ53-1 GACCGAATTCGGATGCAAGCTGCTCGTGG EcoRI 
Δ53-2 GACCGAATTCCGTTGGATGGAGTCTACCAGTCC EcoRI 
Δ54-1 GACCGAATTCGCGGCGTCACTCAGCAAC EcoRI 
Δ54-2 GACCGAATTCGCGAGATCTTCACCGTTGAAGC EcoRI 
12-7-3 CAGCAGAAGCTTTCATCCTGCGGTTTC HindIII 
12-7-5 CAGCAGAAGCTTTCATCCTGCGGTTTC HindIII 
12-7-5C AATTGGATCCATGAGAAAAATCAACGC CG BamHI 
49-blunt ATGAACACCCCCAATAGC n/a 
49-HindIII CAGCAAGCTTTCGAGGCGTCATCCT HindIII 
49-Kpn CAGCGGTACCTTGCGTTCAGTTCCG KpnI 
49D1 CAGCAAGCTTTCAGCCATTGGTCCGCGAGC HindIII 
49D2 CAGCAAGCTTTCAGCCCGGAAAGGACGACA HindIII 
49D3 CAGCAAGCTTTCAGCCTCTCACCGAGGCGC HindIII 
49D4 CAGCAAGCTTTCACAAGAACAGGAGAGTGTCCA HindIII 
49D5 CAGCAAGCTTTCACCGGCGTTGATTTTTCG HindIII 
p17-5 GATCGGATCCATGCTCACAACTGCTGAAG BamHI 
21-Hind CAGGAAGCTTCAACCCCGAACTTCTACTC HindIII 
F1-F GACCAGATCTGATCTGGATCGATCACTACGACC BglII 
F1-R GACCAAGCTTCCGATGTGGCACCGTT HindIII 
43-3 CAGCAGTCTAGACGTGTCGACGAACAGC XbaI 
43-5 CAGCAGTCTAGACGTTGTGCCAGCCGT XbaI 
prom-1 GACGACGAATTCGTCCGACAACACAATTCC EcoRI 
prom-2 GACGACGGATCCTCCTGGGCCTCTTTG BamHI 
prom-3 GACGACGAATTCGATGCGATCTCCTCTGG EcoRI 
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N6-1b CAGGTGATCATGCAACTTGAAGAACTACCAACA
CG 
BclI 
MT-RT-I1 GGACGAGGTCAACCGAGTCACC n/a 
T7CRISPR_F GAAATTAATACGACTCACTATAGGGCTCTTAAT
AAATGCAGTAATACAGGG 
n/a 
CRISPR6R_R CATGGAACTCAACAAGTCTCAGTGTGC n/a 
2.1.6. DNA and protein markers 
2.1.6.1. DNA ladders 
DNA ladder Fragments Source/general remarks 
λ:BstEII 8454, 7242, 6369, 5687, 4822, 
4324, 3675, 2323, 1929, 1371, 
1264, 702 bp 
λ DNA was obtained from 
New England BioLabs or 
Fermentas; final 
concentration of digested 
DNA in a 1x loading dye was 
50 ng/µl (Denaturation of 
cos-fragments at 65° C for  
10 min when necessary) 
 
pUC19:HaeIII 587, 458, 434, 298, 257, 174, 
102, 80, 18, 11 bp 
final concentration of 
digested DNA in a 1x loading 
dye was 50 ng/µl 
 
MassRuler™ 
DNA Ladder 
Mix, ready-to-use 
80, 100, 200, 300, 400, 500, 600, 
700, 800, 900, 1031, 1500, 2000, 
2500, 3000, 4000, 5000, 6000, 
8000, 10000 bp 
 
Fermentas; #SM0403 
GeneRuler™ 1kb 
DNA Ladder  
250, 500, 750, 1000, 1500, 2000, 
2500, 3000, 3500, 4000, 5000, 
6000, 8000, 10000 bp 
Fermentas; #SM0311 
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2.1.6.2. Protein ladders 
Protein Ladder Fragment Sizes Source 
Unstained Protein 
Molecular Weight 
Marker 
 
116, 66.2, 45, 35, 25, 18.4, 
14.4 kDa 
Fermentas; #SM0431 
 
PageRuler™ Unstained 
Protein Ladder 
 
10, 15, 20, 25, 30, 40, 50, 60, 70, 
85, 100, 120, 150, 200 kDa 
Fermentas; #SM0661 
 
PageRuler™ Plus 
Prestained Protein 
Ladder 
10, 15, 25, 35, 55, 70, 100, 130, 
250 kDa 
Fermentas; #SM1811 
 
2.1.7. Enzymes and corresponding buffers 
2.1.7.1. Restriction 
All restriction enzymes were obtained from Fermentas and used with the provided 
buffers. Double digestions were performed in BamH1 buffer whenever possible or 
else with the recommended buffer according to the Fermentas DoubleDigestTM 
webpage (http://www.fermentas.com/en/tools/doubledigest).  
2.1.7.2. PCR 
Polymerase Source 
Pwo (from Pyrococcus woesii) Peqlab 
 
CrimsonTaq 
 
New England 
BioLabs 
 
GoTaq Promega 
 
Pfu (from Pyrococcus furiosus) Promega 
 
The listed enzymes were used with the provided buffers. 
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2.1.7.3. Other enzymes 
Enzyme Source 
T4 Ligase Fermentas* 
 
Klenow Fragment Fermentas* 
 
DNAse I Fermentas* 
 
Proteinase K Roche** 
 
*enzymes were used with the appropriate buffers and/or in concentrations recommended by the 
manufacturer 
** Proteinase K was used in concentrations experimentally determined to be most suitable for 
spheroblasts formation (see section 2.2.2.) 
2.1.8. Antibodies 
For detection of His-tagged proteins an α-His-tag antibody conjugated with 
horseradish peroxidase (HRP) was used. This type of antibody renders a second 
antibody unnecessary and accelerates the detection procedure. The conjugated 
α-His-tag antibody was used in a 1:5000 dilution in TBS-T buffer containing 0.6 % 
Bovine Serum Albumin (BSA). 
2.1.9. Buffers and solutions 
2.1.9.1. Generation of CaCl2 competent E. coli cells 
MOPS I 
 100 mM  MOPS 
 10 mM CaCl2 
 10 mM RbCl2 
 pH  7.0 (KOH) 
 
MOPS II 
 100 mM  MOPS 
 70 mM CaCl2 
 10 mM RbCl2 
 pH  6.5 (KOH) 
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MOPS  IIa 
 100 mM  MOPS 
 70 mM CaCl2 
 10 mM RbCl2 
 15 %  glycerol 
 pH  6.5 (KOH) 
 
2.1.9.2. Transformation of Nab. magadii 
Buffered High Salt Spheroblasting 
Solution (with or without glycerol) 
 
 2 M  NaCl 
 27 mM KCl 
 50 mM Tris-HCl 
   pH 8.2 
 15 %  sucrose 
 (15 %  glycerol) 
 Unbuffered High Salt Spheroblasting 
 Solution 
 
  2 M  NaCl 
  27 mM KCl 
  15 %  sucrose 
 
2.1.9.3. Isolation of φCh1 virus particles 
Solution 1.1 
 2 M  NaCl 
 50 mM Tris-HCl pH 9.5 
 0.6 M  CsCl 
 
Solution 1.3 
 2 M NaCl 
 50 mM Tris-HCl pH 9.5 
 2.7 M CsCl 
Solution 1.5 
 2 M  NaCl 
 50 mM Tris-HCl pH 9.5
 4 M  CsCl 
High salt alkaline solution 
 4 M  NaCl 
 50 mM Tris-HCl pH 9.5  
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2.1.9.4. DNA methods 
2.1.9.4.1. Electrophoresis 
50x TAE 
 2 M Tris-HCl 
 1 M Acetic Acid 
 0.1 M EDTA 
 pH 8.2 
5x DNA sample buffer (with or without 
XC / Orange G) 
 50 mM Tris-HCl 
 0.1 %  SDS 
 0.05 %  bromphenol blue
   (BPB) 
 (0.05 % Xylene  
   Cyanol (XC)) 
 (0.05 % Orange G) 
 pH 8.2 
 after autoclaving add sucrose to a 
 concentration of 25 % 
 
10x TBE 
 108 g Tris base  
 55 g boracic acid  
 0.5 M EDTA pH 8 
 add ddH2O to 1 l  and adjust 
 pH 8.0 (boracic acid) 
 
 
6 % Polyacrylamide gel 
 1.2 ml 30 % PAA (29:1) 
 4.8 ml 1x TBE 
 60 µl 10 % APS 
 6 µl TEMED 
 
2.1.9.4.2. Gel extraction from polyacrylamide gels 
Elutionbuffer 
10 mM EDTA pH 8 
10 mM MgAc.4H2O 
0.5 M NH4OAc 
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2.1.9.5. Protein methods 
2.1.9.5.1. SDS-PAGE and Western blot 
30 % AA-solution (29:1) 
 29 %  acryl amide 
 1 % N,N’–methylene  
  bisacrylamide 
 
4x separation gel buffer 
 1.5 M  Tris-HCl pH  8.8 
 0.4 %  SDS 
 
4x stacking gel buffer 
 0.5 M  Tris-HCl pH 6.8 
 0.4 % SDS 
 
2x protein sample buffer 
 0.12 mM  Tris-HCl pH  6.8 
 4 %   SDS 
 17.4 %  glycerol 
 2 %   β-mercapto- 
   ethanol 
 0.02 %  bromphenol blue 
 
10x SDS-PAGE running buffer 
 0.25 M  Tris base 
 1.92 M  glycine 
 1 %   SDS 
 
Coomassie staining solution 
 25 %  methanol 
 10 %  acetic acid 
 0.15 %  Coomassie  
   Brilliant Blue 
   R-250 
 
Coomassie destaining solution 
 25 % methanol 
 10 % acetic acid 
Ponceau S solution 
 0.5 %  Ponceau S 
 3 %  TCA 
 
Transblot buffer 
 48 mM Tris base 
 39 mM glycine 
 0.037 % SDS 
 20 %   methanol 
10x TBS(-Tween) 
 250 mM Tris-HCl  
 1.37 M  NaCl 
 27 mM  KCl 
 (0.05 % Tween 20) 
 pH 8 
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5 mM sodium phosphate buffer 
A) 0.2 M NaH2PO4.2H2O 
B) 0.2 M Na2HPO4 
Mix 2.55 ml of A and 2.45 ml of B. 
Add ddH2O to 200 ml.  
 
 
2.1.9.5.2. Protein purification under native conditions 
Lysis buffer  
 50 mM NaH2PO4  
 300 mM NaCl  
 10 mM  imidazole  
 adjust pH to 8.0 using NaOH 
 
Wash buffer  
 50 mM  NaH2PO4  
 300 mM  NaCl  
 20 mM  imidazole  
 adjust pH to 8.0 using NaOH. 
Elution buffer  
 50 mM  NaH2PO4  
 300 mM  NaCl  
 250 mM  imidazole  
 adjust pH to 8.0 using NaOH. 
Column buffer* 
 20 mM Tris-HCl pH 7.5 
 200 mM NaCl 
 1 mM  EDTA 
 1 mM  sodium azide 
 1 mM  DTT 
 
* column buffer was used for native purification of maltose tagged proteins 
2.1.9.5.3. Protein purification under denaturing conditions 
Buffer B (lysis buffer) 
 100 mM NaH2PO4 
 10 mM Tris-HCl 
 8 M  urea 
 pH  8.0 (NaOH) 
 
Buffer C (washing buffer) 
 100 mM NaH2PO4 
 10 mM Tris-HCl 
 8 M  urea 
 pH  6.3 (HCl) 
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Buffer E (elution buffer) 
 100 mM NaH2PO4 
 10 mM Tris-HCl 
 8 M  urea 
 pH  4.5 (HCl) 
 
 
2.1.9.5.4. Inclusion body purification from E. coli 
Buffer A (+ sucrose) 
 50 mM Tris-HCl pH 7.5 
 50 mM EDTA 
 5 % (v/v) Triton X-100 
 (8 % (w/v) sucrose) 
Washing buffer 
 50 mM Tris-HCl pH 7.5 
2.1.9.5.5. Protein renaturation 
a) Dialysis 
5x GBB  
 50 mM Tris-HCl pH 8 
 25 mM EDTA 
 30 %  glycerol 
 5 mM  DTT (add just 
   before  use) 
 
 
b) Size exclusion chromatography 
Renaturation buffer  
 50 mM  NaH2PO4  
 300 mM  NaCl  
 adjust pH to 8.0 using NaOH. 
 
 
c) Gel extraction 
Coomassie staining solution (w/o fixation) 
 0.2 % methanol 
 0.5 % TCA 
 0.1 % Coomassie Brilliant  Blue R-250 
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2.1.10. Bandshift assays 
5x GBB  
 50 mM Tris-HCl pH 8 
 25 mM EDTA 
 30 %  glycerol 
 5 mM  DTT (add just 
   before use) 
 
10x Bandshift running buffer 
 70 mM Tris-Hcl pH 8 
 30 mM NaOAc 
 20 mM EDTA 
BSA stock solution 
 1 mg/ml BSA in ddH2O 
 Store at -20° C 
 
2.2. Methods 
2.2.1. Preparation and transformation of CaCl2 competent E. coli 
cells  
100 ml LB-medium containing the respective antibiotics (refer to section 2.1.3.1.) 
were inoculated with an overnight culture of the particular E. coli strain to an 
OD600 of approx. 0.1. The culture was then incubated at 37° C under constant 
shaking until and OD600 of 0.6 – 0.8 was reached. Subsequently, cells were collected 
by centrifugation for 10 min at 10 krpm at 4° C. The pellet was resuspended in 
40 ml ice cold MOPS I solution and incubated another 10 min on ice. The cell 
suspension was again centrifuged and the resulting pellet was resuspended in 
40 ml ice cold MOPS II solution and incubated for 30 min on ice. After another 
centrifugation step the pellet was thoroughly resuspended in 2 ml MOPS IIa 
solution. Aliquots of 100 µl each were directly used for transformation or 
immediately frozen to -80° C for use at a later time point. 
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For transformation aliquots of competent cells, if frozen, were thawed on ice and 
DNA was added in proper amounts*. After incubation on ice for 30 min cells were 
heat shocked by putting them to 42° C for 2 min. Thereafter the cells were put back 
on ice for a short time. Then 300 µl of LB medium were added per batch and for 
regeneration the cells were put on 37° C for 30 min without shaking. Eventually 
each batch was divided into three equal portions that were plated on selective agar 
plates. 
*for XL-1 Blue strains 1 µl of plasmid DNA prepared with commercially available mini prep 
kits was sufficient to give enough transformants. When transforming a ligated vector the 
total 15 µl ligation mix (see section 2.2.4.7.5.) were used. Strains intended for 
overexpression of recombinant protein (Tuner, Bl21(DE3), Rosetta, C41(DE3), C43(DE3)) 
had to be transformed with 5 - 7 µl of plasmid DNA prepared with commercially available 
mini prep kits obtained from Fermentas, PEQLAB or QIAGEN.  
2.2.2. Preparation and transformation of competent Nab. magadii 
cells 
Pre-cultures that had been grown to late log phase were used for inoculation of 
NVM+ medium containing 70 µg/ml bacitracin to an OD600 of approx. 0.1. For faster 
growth this was done in baffled flasks. Cultures were then incubated at 37° C, 
shaking, until they reached an OD600 of 0.5 – 0.6. Then the cells were collected by 
centrifugation with 6 krpm for 15 min at room temperature and the pellet was 
thoroughly resuspended in high salt buffered spheroblasting solution with glycerol 
(in half of the volume of the initial culture). Subsequently proteinase K was added 
to a concentration of approx. 20 µg/ml (or 0.6 mAU/ml) and the batch was 
incubated at 42° C, while shaking, until spheroblasts had formed. Usually this took 
approx. 48 h and spheroblast formation was visually confirmed by light microscopy. 
Transformation of Nab. magadii competent cells was done on the basis on the 
earlier described PEG-600 method (Charlebois et al., 1987; Cline & Doolittle, 1987). 
Batches of 1.5 ml of spheroblasts were taken for each single transformation. Cells 
were collected by centrifugation at 10 krpm for 3 min at room temperature using a 
microcentrifuge. The pellet was carefully resuspended in 150 µl of buffered high 
salt spheroblasting solution (w/o glycerol) and 15 µl of a 0.5 M EDTA solution (pH 
8) were added and incubated at room temperature for 10 min. Subsequently the 
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respective DNA was added, usually in an amount of 3 µg total, and incubated for 
another 5 min at room temperature. Then 150 µl of a 60 % PEG-600 solution 
(therefore frozen amounts of PEG-600 were heated to 65° C and solubilized in 
unbuffered high salt spheroblasting solution immediately before use) were added 
and the batch was incubated for 30 min at room temperature. For washing 1 ml of 
NVM+ was added and cells were collected by centrifugation at 10 krpm for 5 min at 
room temperature using a microcentrifuge. The supernatant was removed 
completely and the pellet was thoroughly resuspended in 1 ml of fresh NVM+. For 
regeneration the batch was put onto a thermomixer and incubated at 37° C, while 
shaking, until no more spheroblasts were visible (or alternatively 24 – 48 h). Then 
100 µl of the batch were plated per selective agar plate and incubated at 37° C until 
colonies were visible (usually 10 – 21 days).  
For confirmation of transformants single colonies were inoculated in 1 ml or 15 ml 
of fresh selective NVM+ and incubated at 37° C while shaking until the culture 
reached stationary phase. Then 100 µl of the culture were taken and cells were 
harvested by centrifugation at 11.2 krpm for 3 min at room temperature. The pellet 
was resuspended in 100 µl of autoclaved ddH2O resulting in lysis of the cells.  
1 – 2 µl of lysed cells were taken as template for PCR using primers suitable for 
verification of the clone. 
2.2.3. Phage methods 
2.2.3.1. Isolation of φCh1 virus particles 
A fresh plaque of Nab. magadii lysogenic strain L11 was inoculated in NVM+ and 
grown to an OD600 of approx. 0.5 – 0.6 (before onset of lysis). If sealed, this culture 
can be kept for months at room temperature for repeated use. 
From the above culture a larger amount of NVM+ (usually 60 – 120 ml) could be 
inoculated and grown to an OD600 of approx. 0.5 – 0.6. This pre-culture was then 
used to inoculate large quantities of NVM+ (4.5 l – 3 x 1.5 l). The growth curve of 
this large culture was monitored by measuring OD600 1 – 2 x per day. It was grown 
beyond the onset of lysis until OD600 had dropped to 0.4 – 0.5. Subsequently the 
batch was spun at 8 krpm for 20 min at room temperature to remove cells and cell 
debris. To the supernatant (containing the virus particles) 10 % (w/v) of PEG 6000 
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was added and stirred over night in order to precipitate the phage particles. On the 
next day the batch was centrifuged (same conditions as before) and the pellet was 
resuspended in 50 ml of high salt alkaline solution.  
Further purification of virus particles was performed with the aid of a 
discontinuous CsCl density gradient. The gradient was build up in Beckman 
ultracentrifuge tubes by carefully layering CsCl solutions of different densities over 
each other. This was done in the following order (from bottom to top): 2 ml of 
solution 1.5, 5 ml solution 1.3, 6 ml of phage suspension and approx. 1 ml of 
solution 1.1. The gradient was centrifuged at 30 krpm for 20 h at room temperature 
resulting in one lower band containing Nab. magadii flagella and one or two* upper 
bands representing the virus particles. The upper band(s) was/were carefully 
removed in the smallest volume possible and further purified by the use of a 
continuous gradient. Therefore the virus particles were mixed with an equal 
volume of solution 1.3 and centrifuged again at 30 krpm for 20 h at room 
temperature.  The resulting band was removed carefully – again in the smallest 
volume possible and dialyzed two times overnight against high salt alkaline 
solution in order to remove the cesium.   The quantity of infectious φCh1 virus 
particles was determined via phage titer analysis as described below. 
*if two bands occurred they lay very closely together, probably representing two fractions of 
differently methylated viral DNA. 
2.2.3.2. Determination of phage titers by soft plating technique  
Respective Nab. magadii L13 strains were grown to late log or stationary phase. 
Then 5 ml of NVM+ soft agar were mixed with 400 µl of respective L13 culture as 
well as with 100 µl of phage dilution (purified virus particles in dilutions of 10-7, 
10-6, 10-5, 10-4, 10-3 and 10-2 in NVM+). The mixture was poured onto selective or 
non selective rich medium plates, respectively. Each batch was done in duplicates 
and plates were incubated at 37° C until plaques were visible (10 – 21 days). 
2.2.3.3. Isolation of φCh1 virus DNA 
300 µl of purified virus particles (see section 2.2.3.1.) were mixed with 900 µl of 
autoclaved ddH2O. Subsequently two Phenol/Chloroform extractions were 
performed using 600 µl Phenol/Chloroform (1:1). The aqueous phase was mixed 
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with 2.5 x vol. of 96 % Ethanol (-20° C) and put to -80° C for 15 min. Precipitated 
DNA was collected by centrifugation at 16.4 krpm for 30 min at 4° C using a 
refrigerated microcentrifuge. The resulting pellet was washed twice with 1 ml of 
70 % Ethanol and then the pellet was air dried and solubilized in 25 µl of 
autoclaved ddH2O. Successful DNA isolation was confirmed by agarose gel 
electrophoresis.  
2.2.4. DNA Methods 
2.2.4.1. Agarose gel electrophoresis 
The respective amount of agarose* was mixed with 1x TAE buffer and heated in a 
microwave until it was completely melted. Then the molten agarose was cooled and 
cast into the provided gel tray. Combs were put into the agarose and the system 
was cooled until the agarose had become solid. Subsequently the combs were 
removed and the gel tray was put into the suitable electrophoresis apparatus that 
had been filled with 1x TAE buffer. Then 1x TAE was added until the gel was 
slightly overlaid with buffer.  Afterwards the combs were removed and the 
corresponding slots were ready to be loaded. DNA samples were prepared by 
mixing 3 or 5 µl of respective DNA with 5 µl of 5x DNA sample buffer. Thereafter 
the total volume was loaded onto the gel. Separation of DNA started when power 
was applied (10 V/cm) and migration of DNA fragments could be estimated due to 
the respective dyes that had been added to the sample buffer. After gels had been 
sufficiently run they were put into an ethidium bromide bath (5 mg/l) and stained 
for 15 – 20 min. Subsequently they were shortly rinsed in ddH2O and DNA bands 
were visible under UV light where a picture could be taken. 
*dependant on the application gels containing 0.8 %, 1.1 % or 1.5 % (for resolution of 
smaller fragments) agarose were cast.  
2.2.4.2. Polyacrylamide gel electrophoresis 
For resolution of DNA fragments smaller than 500 bp electrophoresis was carried 
out using polyacrylamide (PAA) gels. Therefore BIORAD´s Mini – Protean® 3 
system was used. Gels (6 % PAA in 1x TBE) were cast according to the 
manufacturers protocol. After the gel had polymerized the gel cassette was put into 
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the provided apparatus, which was subsequently filled with 1x TBE buffer. DNA 
samples were prepared and loaded as described in section 2.2.4.1. Gels were run by 
applying a power of 15 mA per gel. Migration of DNA fragments could be estimated 
through the use of dyes that had been added to the DNA sample buffer. Finished 
gels were left on one of the two sandwich glass plates and carefully put into an 
ethidium bromide bath (5 mg/l) for 5 – 10 min. After staining the gels were shortly 
rinsed in ddH2O and DNA bands were visualized and photographed using UV light.  
2.2.4.3. Polymerase chain reaction (PCR) 
The polymerase chain reaction allows amplification of a DNA region of interest. In 
the context of this work PCR was used to amplify certain DNA fragments for 
(i) cloning or bandshifiting (preparative PCR) or (ii) to confirm positive clones 
(analytical PCR). Most of the PCRs, especially those for generation of DNA 
fragments that were used for cloning, were done using, Pwo Polymerase (Peqlab), 
as it has a proof reading function. In cases where Pwo did not give sufficient yield 
Pfu Polymerase (Promega) or Taq polymerase (Promega, NEB) was used. For 
analytical purposes Taq polymerase was used most frequently. Polymerases were 
used in amounts described in section 2.2.4.3.3.; elongation temperature and -time 
were set up as recommended by the provider. 
2.2.4.3.1. Primers 
Forward and reverse primers were obtained from VBC genomics in a lyophilized 
state. Upon delivery ddH2O was added to give a stock concentration of 1 µg/µl and 
primers were kept at -20° C. Primer stocks were diluted 1:10 right before use. 
Melting temperature of primers was calculated using the Gene  
Runner Version 3.01 from Hastings Software, Inc. (available at 
http://www.generunner.net/). In the PCR program the annealing temperature 
initially was set to be 4° C below the lower melting temperature of both primers 
but had to be adjusted in some cases in order to increase yield. 
2.2.4.3.2. Template DNA 
As template DNA either (i) plasmids purified with a miniprep kit, (ii) purified 
φCh1 DNA or (iii) crude DNA extracts from E. coli or Nab. magadii were used. 
Crude extracts from E. coli were created by taking 5 µl of an overnight culture, 
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adding 100 µl of ddH2O and heating to 95° C for 5 – 10 min. For Nab. magadii 
100 µl of culture were taken and cells were collected by cenntrifugation at 
11.2 krpm for 3 min at room temperature. Afterwards the pellet was resuspended 
in 100 µl of ddH2O. Alternatively a single colony from an agar plate could be taken 
and put directly into 50 – 100 µl of ddH20.  
While crude extracts were taken undiluted (1 – 2 µl) per PCR, plasmids (purified 
with the GeneJET™ Plasmid Miniprep Kit from Fermentas) or φCh1 DNA were 
diluted 1:30 before use in PCR (1 – 2 µl). 
2.2.4.3.3. PCR batches and -programs 
Below the batch sizes for preparative PCRs are listed. For analytical purposes the 
batch sizes were reduced to ½, or even to ¼ in some cases.  
Batch for Pwo 
 
 67 µl ddH20 
 10 µl 10x Pwo buffer 
 10 µl 2 mM dNTPs 
 5 µl  Forward primer (500 ng) 
 5 µl  Reverse primer (500 ng) 
 1 µl* template DNA 
 2 µl  Pwo Polymerase 
 
  Program for Pwo 
 
    94° C  5 min 
    94° C  1 min 
    Ann.Temp. 1 min 
    68° C   1 min/kbp 
    68° C  5 min 
      4° C  infinite 
Batch for Taq (GoTaq® or 
CrimsonTaqTM) of Pfu 
 
 20 / 10 µl 5x Taq / 10x Pfu buffer  
 58 / 68 µl ddH2O 
  10 µl 2 mM dNTPs 
  5   µl  Forward primer (500 ng) 
  5   µl  Reverse primer (500 ng) 
  1   µl* template DNA 
  1   µl  of the respective  
   polymerase 
 
  Program for Taq and Pfu 
 
   94° C  5 min 
   94° C  1 min 
   Ann.Temp. 1 min 
   72° C   1 min/kbp 
   72° C  5 min 
     4° C  infinite 
*if more than 1 µl of DNA was used the volume of ddH2O was adjusted to maintain the 
total volume of the batch  
  
33 
cycles 
33 
cycles 
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2.2.4.3.4. Confirmation and purification of PCR products 
Successful PCR was confirmed by gel electrophoresis (agarose or polyacrylamide 
gels). For preparative purposes, and when no interfering side products could be 
detected on a gel, the PCR product was purified using the QIAquick PCR 
Purification kit from QIAGEN. This kit is based on the principle that the PCR 
product is bound to a silica column, washed with ethanol and eluted afterwards.  
Thus unwanted reagents like the PCR buffer, or excess nucleotides and primers 
were removed. The PCR product was usually eluted with ddH2O in half of the 
initial batch volume, i.e. 50 µl. However, in cases where PCR yield was 
substantially low elution volume was adjusted to raise DNA concentration to 
reasonable values. The success of the purification was again confirmed via gel 
electrophoresis.  
2.2.4.4. Plasmid isolation from E. coli 
For plasmid preparation from E. coli was done using the GeneJET™ Plasmid 
Miniprep Kit from Fermentas and following the provided protocol. However, 
instead of 1.5 ml 3 ml of an overnight culture of the respective E. coli strain 
(carrying the plasmid of interest) were taken for plasmid isolation. Elution of 
plasmid DNA from the silica column was done with 50 µl of ddH2O. Samples of the 
isolated plasmids were loaded onto an agarose gel in order to confirm the plasmid 
preparation.  
2.2.4.5. Gel extraction of DNA fragments from agarose gels 
In cases where PCR gave more than one product or where the DNA fragment of 
interest had to be retained from a digested plasmid the respective fragment had to 
be cut out from a gel. The complete DNA sample was mixed with 5x DNA sample 
buffer and the total volume of the resulting mix was loaded onto a 0.8 or 1.5 % 
agarose gel (according to the size of the DNA of interest) in portions of 20 or 25 µl 
per slot. For example, if the DNA sample had a volume of 100 µl it was mixed with 
20 µl of 5x DNA sample buffer and loaded onto a gel using 6 slots each loaded with 
20 µl of sample. After the gel had sufficiently run it was put into a freshly prepared 
ethidium bromide bath (5 mg/l) and stained as short as possible (usually 3 min). 
Afterwards the gel was rinsed shortly with dH2O und bands were visualized using 
UV light. The band of interest was cut out of the gel with a scalpel, making the 
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UV exposure as short as possible. Gel slices were transferred into Eppendorf tubes. 
Extraction of the DNA fragments from the gel slices was done by using the 
QIAquick Gel Extraction kit from QIAGEN and following the provided protocol. 
The result and purity of the extracted DNA fragment were controlled by gel 
electrophoresis.  
2.2.4.6. Gel extraction of DNA fragments from polyacrylamide gels 
For DNA fragments around 500 bp in length or shorter extraction from PAA gels 
had to be performed. As described in section 2.2.4.5. the DNA samples were mixed 
with 5x DNA sample buffer and loaded onto PAA gels. However, since the slot 
volume was smaller a maximum of 10 µl per slot could be loaded. After the gel had 
been run it was put into a freshly prepared ethidium bromide bath (5 mg/l), stained 
for approx. 1 – 2 min and shortly rinsed in dH2O. Bands of interest were carefully 
cut out of the gel by using a scalpel and put into Eppendorf tubes. Subsequently 
the gel slices within the tubes where thoroughly crushed using a blue or yellow 
pipette tip. Then approx. 300 – 400 µl of elutionbuffer (alternatively 2 x the weight 
of the gel slice) were added and the tubes were incubated on a thermomixer at 
37° C overnight, shaking. On the next day the PAA had to be removed completely. 
Therefore the tubes were spun at 13.2 krpm for 5 min at room temperature and the 
supernatant was transferred into a new tube. This step was usually done 2 – 3 
times combining the supernatants. As a last step the united supernatants were 
centrifuged again and the resulting supernatant was put into a fresh tube. The 
DNA was then purified from the supernatant by using the QIAquick PCR 
Purification kit from QIAGEN. DNA was eluted from the silica columns with 50 µl 
of ddH2O. The result and purity of the extracted DNA fragment were controlled by 
gel electrophoresis. 
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2.2.4.7. Cloning in E. coli strains 
2.2.4.7.1. Restriction of DNA  
Digestion of the respective DNA fragments was done using enzymes and 
corresponding buffers provided by Fermentas in the recommended concentrations. 
Full digestion of DNA was achieved by an incubation time of at least 3 h or even 
overnight (if no star activity) at the recommended temperature. For analytical 
purposes, i.e. testing for a specific DNA fragment within a plasmid, restriction time 
was lowered to 1 h.  
2.2.4.7.2. Purification of DNA 
After digestion of DNA buffers and nucleotides or tiny DNA fragments had to be 
removed in order to obtain the pure DNA fragment of interest. This was done with 
the aid of the QIAquick Purification kit from QIAGEN following the provided 
protocols. Usually, DNA was eluted from the silica column with ddH2O, in half of 
the initial volume. In cases where the digested DNA fragment of interest was 
obtained by extraction from a gel no further purification was necessary (since the 
result of the extraction is an already purified DNA fragment).  
2.2.4.7.4. Blunting DNA with the Klenow fragment 
For some cloning strategies blunt ends were required. In order to produce blunt 
ends from sticky ends created by digestion with certain restriction enzymes the 
Klenow fragment of E. coli polymerase I was used as it fills up 5´ overhangs if 
sufficient dNTPs are provided. Batches contained 100 – 200 µM dNTPs (each) and 
were incubated at 37° C for 30 min followed by inactivation of the enzyme at 75° C 
for 15 min.  
2.2.4.7.5. Ligation of respective DNA fragments 
DNA fragments with matching ends (e.g. DNA sequence of interest and respective 
vector) were ligated using T4 Ligase and the corresponding buffer both provided by 
Fermentas. Ligation was done either at room temperature for 3 h or at 16° C 
overnight.  
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Batches were composed as follows: 
   11.5 µl  DNA fragment of interest 
   1 µl  corresponding vector 
   1.5 µl  T4 ligase buffer (Fermentas) 
   1 µl  T4 ligase (Fermentas) 
 
After the reaction the total volume of 15 µl could be used for transformation of 
E. coli (see section 2.2.1.). 
2.2.4.7.6. Pre-screening of candidates by quick plasmid preparations 
After transformation colonies were screened for possible positive candidates.  
20 – 40 test tubes each containing 5 ml of LB medium and respective antibiotics 
were inoculated with one colony each and incubated overnight at 37° C while 
shaking. Subsequently 300 µl of each culture were transferred to an Eppendorf 
tube and cells were harvested by centrifugation at 13.2 krpm for 3 min at room 
temperature using a microcentrifuge. The pellets were each resuspended in 30 µl of 
5x DNA sample buffer. Upon addition of 14 µl of Phenol/Chloroform (1:1) the tubes 
were vigorously vortexed for 30 sec and afterwards centrifuged at 13.2 krpm for 
7 min at room temperature. 12 µl of the aqueous phase (containing the nucleic 
acids) were loaded onto a 0.8 % agarose gel.   After the gel was run and stained it 
showed plasmid DNA, as well as chromosomal DNA and larger RNA fractions. 
Although the size of nonlinear DNA, i.e. plasmids, cannot be estimated putting 
many plasmids side by side on such gels reveals size differences, assuming that 
plasmids carrying the sequence of interest run higher than others. This way for 
each different plasmid species the corresponding culture was picked for deeper 
testing and verification of the clones.  
2.2.4.7.7. Verification of positive clones 
From every culture that has been selected by quick plasmid preparation (see above) 
plasmid DNA was isolated as described in section 2.2.4.4. The obtained plasmids 
were tested for the respective DNA insert of interest either by restriction analysis 
(see section 2.1.7.1.) or by PCR (see also section 2.2.4.3.). 
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2.2.4.7.8. Storage of verified clones 
Plasmid DNA of verified clones was kept at -20° C. In addition to that 20 – 25 ml of 
selective LB were inoculated with the original culture and grown overnight at 
37° C. From this culture 1 ml was transferred into a cryotube, mixed with 800 µl of 
sterile 50 % gylcerol and immediately frozen to -80° C.  
2.2.4.7.9. Cloning strategies 
pRo-7: 
A preparative PCR was done from total φCh1 DNA using TR-31 and Ro-7 as 
primers. The obtained 1469 bp fragment (nu. 34689 – 36157) was digested 
with SmaI and XbaI. The vector pKSII+ - TR4/Ro6 - TR3/Ro7 was digested 
with these enzymes as well and the larger fragment of approx. 4800 bp, 
being the remaining vector, was extracted from a 0.8 % agarose gel. Both, 
the PCR fragment, as well as the vector were ligated and transformed into 
E. coli. Thereafter the resulting vector was isolated and digested with 
NotI/HindIII. The fragment of interest (approx. 3700 bp) was extracted from 
an agarose gel and cloned into plasmid pNov-1, which had previously been 
digested with NotI/HindIII.  
pRo-8: 
A preparative PCR was performed with primers TR-1 and Δ-53-1 using 
total φCh1 DNA as template. The resulting 1089 bp fragment was digested 
with NotI/EcoRI and cloned into the plasmid pKSII+ giving rise to vector 
pΔ53-1. The latter was digested with HindIII/EcoRI and ligated with the 
2717 bp fragment obtained from PCR by using primers TR-4 and Δ53-2 that 
has been previously digested with the same enzymes. Upon transformation 
in E. coli the new vector p Δ53-2 could be isolated. Subsequently it was 
digested with NotI/HindIII and the corresponding fragment of approx. 
3600 bp was isolated and cloned into vector pNov-1. 
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pRo-9: 
A preparative PCR was performed with primers TR-1 and TR-4 using 
existing plasmid pRo-5 as template. The resulting fragment of approx. 
3600 bp was digested with NotI/HindIII and cloned into vector pNov-1 
which had previously been digested with NotI/HindIII as well.  
pRo-10: 
A preparative PCR was performed with primers TR-1 and TR-4 using 
existing plasmid pRo-7 as template. The resulting fragment of approx. 
3600 bp was digested with NotI/HindIII and cloned into vector pNov-1 
which had previously been digested with NotI/HindIII as well.  
pRo-11: 
A preparative PCR was performed with primers TR-1 and Δ-54-1 using 
total φCh1 DNA as template. The resulting 2254 bp fragment was digested 
with NotI/EcoRI and cloned into the plasmid pKSII+ giving rise to vector 
pΔ54-1. The latter was digested with HindIII/EcoRI and ligated with the 
1554 bp fragment obtained from PCR by using primers TR-4 and Δ54-2 that 
has been previously digested with the same enzymes. Upon transformation 
in E. coli the new vector p Δ54-2 could be isolated. Subsequently it was 
digested with NotI/HindIII and the corresponding fragment of approx. 
3600 bp was isolated and cloned into vector pNov-1. 
pRo-5-ORF49Δ1-5: 
Preparative PCRs were performed using total φCh1 DNA as template and 
49-Kpn as a 5´ primer. In order to generate fragments of different lengths 
different 3´ primers were used (49D1, 49D2, 49D3, 49D4 and 49D5). The 
obtained fragments were digested with KpnI and HindIII and cloned into 
plasmid pRo-5.  
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pRSETA-ORF49: 
Though ORF49 had previously been cloned into pRSETA (Meissner, 2008) 
cloning was re-done for this thesis. A preparative PCR was performed with 
primers 12-7-3 and 12-7-5 using total φCh1 DNA as a template. The 
resulting 354 bp fragment was digested with BamHI/HindIII and cloned 
into the vector pRSETA. 
pMal-c2X-ORF49: 
A preparative PCR was performed with primers 49-blunt and 49-HindIII 
using total φCh1 DNA as a template. The resulting fragment was cloned in 
frame into a pMal-c2X vector that had been digested with HindIII and 
XmnI. 
pRSETA-ORF49Δ1 – Δ5: 
Preparative PCRs were performed with 12-7-5 as a 5´ primer and different 
3´ primers (49D1, 49D2, 39D3, 49D4 and 49D5) using total φCh1 DNA as a 
template. The resulting fragments were digested with BamHI/HindIII and 
cloned into the vector pRSETA. 
pRSETA-ORF49ΔN: 
A preparative PCR was performed with primers 12-7-3 and 12-7-5C using 
total φCh1 DNA as a template. The resulting fragment was digested with 
BamHI/HindIII and cloned into the vector pRSETA. 
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2.2.5. Protein methods 
2.2.5.1. Overexpression of recombinant protein and screening of 
cultures for optimal time point for cell harvesting 
For expression of heterologous recombinant protein in E. coli, the respective strain 
was transformed with the desired expression vector (see section 2.1.4.), plated on 
selective LB agar and incubated over night at 28° C or 37° C, respectively*. Several 
of the resulting colonies were used to inoculate 25 ml of LB selective media each. 
After overnight incubation at 28° C or 37° C 1 ml of each culture was stored as 
glycerol stock (as described in section 2.2.4.7.8.) for possible later use while the rest 
of the culture was used to inoculate 100 ml of fresh selective medium to an OD600 of 
0.1. These cultures where grown at different temperatures and growth curves were 
monitored by measuring the OD600. At an OD600 of 0.3 – 0.5 the overexpression of 
the desired protein was induced by adding a 1 M IPTG stock solution to a final 
concentration of 0.5 mM IPTG within the growth medium. To prepare crude 
extracts samples were taken immediately before induction and thereafter every 
hour for 4 – 5 h. In addition to that one sample was taken the following morning.  
In order to prepare raw extracts, at a certain time point with a known OD600 1.5 ml 
of the respective culture were transferred into an Eppendorf tube and centrifuged 
at 13.2 krpm for 3 min at room temperature.  The pellet was resuspended in 
75 x OD600 µl of 5 mM sodium phosphate buffer and mixed with the same volume of 
2x protein sample buffer. Raw extracts were then boiled at 95° C for 10 min. 
Obtained samples were analyzed by SDS-PAGE in order to find the optimal time 
point, i.e. time point of maximal expression, for harvesting the cells. 
*in order to reduce the formation of inclusion bodies some E. coli strains were grown at 
28° C instead of 37° C. 
2.2.5.2. Protein purification under native conditions  
2.2.5.2.1. Purification of His-tagged proteins 
1 l of selective LB medium was inoculated to an OD600 of 0.1 with an overnight 
culture of the respective E. coli strain carrying the desired expression vector. The 
culture was grown at 28° C or 37° C to an OD600 of 0.3 – 0.5,  induced with 0.5 mM 
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IPTG and further grown until best time point for cell harvesting. Subsequently the 
cells were collected by centrifugation at 6 krpm for 15 min at 4° C and the pellet 
was resuspended in 50 ml of lysis buffer. As cycles of freezing and thawing enhance 
lysis the suspension was frozen to -20° C overnight. The following day the 
suspension was thawed and a spatula tip full of egg white lysozyme was added 
letting the mixture rotate at 4° C for 3 – 4 h. Afterwards the suspension was 
sonicated under constant cooling until cells were sufficiently lysed (normally it took 
3 – 5 sonication rounds of 3 min each, letting the mixture cool on ice between each 
round). Cell lysis was observed and confirmed under the microscope. Cell debris 
and insoluble proteins were removed by centrifugation at 8 krpm for 20 min at 
4° C. 400 – 500 µl of Nickel Agarose (Ni-NTA) slurry (obtained from QIAgen) were 
added to the supernatant and stirred overnight at 4° C in order to bind the His-
tagged protein to the Ni2+ ions. The following day the suspension was loaded onto a 
designated column provided by the QIAexpressionist™ Kit from QIAgen. The 
flow-through was collected leaving the Ni-NTA with the bound protein as a thin 
layer on the column. This was washed twice with 4 ml of washing buffer 
subsequently followed by elution with 6 x 0.5 ml of elution buffer (elution of 
recombinant protein from Ni-NTA is achieved by raising the Imidazol 
concentration). Samples of all fractions were loaded onto an SDS-PAGE gel for 
analysis of the protein purification.  
2.2.5.2.2. Purification of Maltose-tagged proteins 
100 ml of selective LB medium (containing 0.2 % glucose) were inoculated to OD600 
of 0.1 with an overnight culture of E. coli BL21 carrying the expression vector 
pMal-c2X-ORF49. Cells were grown to an OD600 of approx. 0.6, induced with 
0.3 mM IPTG and further grown for 3 h at 37° C. Afterwards cells were collected by 
centrifugation at 7 krpm at 4° C for 15 min and the resulting pellet was 
resuspended in 30 ml of column buffer. The suspension was frozen to -20° C for 
overnight. Thereafter it was thawed and sonicated 2 x for 3 min each time. 
Remaining cells and cell debris were removed by a centrifugation step (10 krpm, 
4° C, 15 min). The supernatant was transferred into an amylase resin obtained 
from New England BioLabs. After collection of the flow-through the resin was 
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washed 3 x with 1 ml of column buffer. Elution of the protein was achieved with 4 x 
150 µl of column buffer containing 10 mM maltose. Success of purification was 
checked by SDS-PAGE analysis of all fractions.  
2.2.5.3. Purification of His-tagged proteins under denaturing 
conditions 
Cells for purification under denaturing conditions were prepared and harvested as 
described in section 2.2.5.2.1. However, the cell pellet was directly frozen to -20° C 
overnight. After thawing the pellet was resuspended in 50 ml of buffer B* and 
stirred at room temperature for at least 3 h or overnight. Subsequently the 
suspension was sonicated as described in section 2.2.5.2.1. After centrifugation at 
8 krpm for 20 min at 4° C the supernatant was retained adding 400 – 500 µl of 
Ni-NTA slurry and stirring the lysate overnight at room temperature.  
Subsequently the suspension was loaded onto a designated column provided by the 
QIAexpressionist™ Kit from QIAgen. The flow-through was collected and the 
remaining Ni-NTA with the bound protein was washed twice, each time with 4 ml 
of buffer C*. Elution of the recombinant protein from the Ni-NTA slurry is achieved 
by lowering the pH. This was done by adding 6 x 0.5 ml of buffer E*. Samples of all 
fractions were loaded onto an SDS-PAGE gel for analysis of the protein 
purification.  
*as buffer B, C and E contain urea their pH was checked and adjusted each time before use. 
2.2.5.4. Purification of inclusion bodies from E. coli 
Inclusion body purification was performed as previously described (Trachuk et al., 
2005):  1 l of fresh LB containing respective antibiotics was inoculated to an OD600 
of 0.1 with an overnight culture of the respective E. coli strain. Subsequently the 
culture was grown to an OD600 of 0.3 – 0.5 at 28° C and induced with 0.5 mM IPTG 
and further grown at 28° C for 3 h. Cells were harvested by centrifugation at  
6 krpm for 15 min at 4° C. The resulting cell pellet was resuspended in buffer A 
containing sucrose. Thereafter the suspension was sonicated as described in section 
2.2.5.2.1. followed by centrifugation at 2500 g for 40 min. The pellet (containing 
inclusion bodies) was washed once with 40 ml of buffer A (without sucrose), twice 
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with 50 mM (pH 7.5) and one time with 40 ml of ddH2O. Each washing step was 
interrupted by centrifugation at 10.000 g for 30 min. The resulting pellet was 
frozen to -20° C.  
2.2.5.5. Protein renaturation 
2.2.5.5.2. by dialysis 
Purified proteins were transferred into dialysis tubes and dialyzed once against 
1x GBB containing 4 M urea overnight. Subsequently a second dialysis step 
against 1x GBB once more overnight was carried out. The protein solution was 
then transferred into Eppendorf tubes and the solution was clarified of remaining 
insoluble protein by centrifugation at 13.2 krpm for 5 min. Samples of the protein 
solution were analyzed by SDS-PAGE as described in section 2.2.5.6. 
2.2.5.5.3. by solubilization of inclusion bodies and rapid dilution 
Purified inclusion bodies (section 2.2.5.4.) were solubilized in buffer B (section 
2.1.9.5.3.) containing 8 M urea to a final concentration of 5 mg/ml. Another aliquot 
of inclusion bodies was solubilized in 6 M guanidine hydrochloride to a final 
concentration of 1 mg/ml. Both protein solutions were afterwards diluted 1:10, 1:20 
and 1:100 into native elution buffer (section 2.1.9.5.2.) and the result was observed 
on an SDS-Page gel.  
2.2.5.5.4. by size exclusion chromatography 
Approx. 30 ml of sephacryl S200 HR (obtained from Pharmacia Fine Chemicals) 
were equilibrated in renaturation buffer and filled into a BioRad 25 ml column to a 
bed size of approx. 12 cm. 0.5 – 1 ml of protein solution obtained as described in 
section 2.2.5.3 were loaded onto the column. They were eluted under a constant 
flow of renaturation buffer and fractions of 0.5 ml were collected. Fractions were 
sampled for presence of the protein of interest by SDS-PAGE.  
2.2.5.5.5. Gel extraction from polyacrylamide gels  
Proteins obtained as described in section 2.2.5.3 were mixed with an equal volume 
of 2x protein sample buffer and loaded onto an SDS-PAGE gel. After separation the 
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respective bands were cut out of the gel and purified according to the protocol using 
the ElutaTube™ Protein Extraction kit from Fermentas. The success of the 
extraction procedure was checked by SDS-PAGE (see below). 
2.2.5.6. SDS-PAGE  
SDS-PAGE (sodiumdodecylsulfate polyacrylamide gel electrophoresis) allows for 
separation of proteins according to their size. Protein samples are denatured by 
heat in the presence of β-mercaptoethanol (or di-thiotreitol, DTT) and SDS. As an 
anionic detergent SDS covers the native charges of the respective proteins 
rendering their running behavior in an electric field to be independent from their 
net charge. Proteins treated in such way migrate through a PAA gel with respect to 
their molecular weight. However, this is only completely true for (mesophilic) 
proteins with an average distribution of charges. As mentioned in section 
1.1.4.2.1.1. haloalkaliphilic proteins contain a higher than average portion of acidic 
residues. These proteins migrate slower through the gel than a mesophilic protein 
of equal size.  
2.2.5.6.1. Preparation of a discontinuous polyacrylamide gel 
For casting the gels a vertical system from BioRad (Mini Protean 3) was used as 
instructed from the manufacturer. A discontinuous gel consists of a low PAA 
percentage stacking gel above the separation gel. The respective mixtures are 
listed below. 
Reagent 12 % Separation gel  4 % Stacking gel 
   
ddH2O 1750 µl 1233 µl 
Separation gel buffer 1250 µl  
Stacking gel buffer    500 µl 
30 % PAA solution 2000 µl   267 µl 
10 % APS     60 µl     20 µl 
TEMED     10 µl       5 µl 
 
First the separation gel was mixed without APS and TEMED and the mixture was 
placed on ice for cooling. Upon addition of APS and TEMED the gel started to 
polymerize. Then it was rapidly poured into the casting apparatus and overlaid 
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with a thin layer of 2-propanol (approx. 1 mm) in order to obtain a leveled surface.  
After ca. 5 – 15 min when the gel had polymerized the 2-propanol was poured 
away. Subsequently the stacking gel was mixed and cast overlaying the separation 
gel. Before polymerization a comb (10 or 20 wells) was placed into the gel. The 
finished gel was transferred into the provided tank that was filled with 1x SDS 
running buffer according to the manufacturer´s instructions.  
2.2.5.6.2. Sample preparation and running conditions 
Protein samples were mixed 1:1 with 2x protein sample buffer and heated to 95° C 
for 10 min. Then they were either frozen for later use or cooled down on ice and 
applied to a prepared SDS-PAGE gel. The gel was run by applying amperage of 
15 mA/gel (two gels could be run simultaneously per tank). Migration of proteins 
could be estimated due to bromphenol-blue present in the sample buffer. Protein 
separation was stopped either when the bromphenol blue had left the gel (for 
bigger proteins > 20 kDa) or when the dye was about 1 – 1.5 cm away from the end 
of the gel (for smaller proteins < 20 kDa).  
2.2.5.6.3. Staining of separated proteins 
After the gel was run it was carefully removed from the apparatus and put into a 
bath containing Coomassie staining solution. After 15 – 30 min it was transferred 
into destaining solution for another 15 – 20 min or into H2O for destaining over 
night. 
2.2.5.7. Western blot 
The Western blotting technique allows for detection of a specific protein by 
antibodies directed against this protein of interest. In many cases these antibodies 
are then detected with a second antibody that is specific for the first one. This 
second antibody can be labeled in different ways, e. g. radioactively or 
enzymatically and can be visualized according to the labeling method. However, in 
most of the Western blots performed in this work only a single antibody was used. 
Directed against a 6x Histidine tag (which had been fused to the protein of 
interest) it is also conjugated with the horseradish peroxidase (HRP). Thus 
proteins that are recognized by the antibody can be visualized without the 
necessity of a second antibody. 
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2.2.5.7.1. The blotting procedure 
Proteins of interest were separated in an SDS-PAGE gel (see section 2.2.5.6.). Six 
layers of Whatman paper and one layer of Protran nitrocellulose membrane 
(obtained from Whatman) were cut into the size of the gel. Subsequently all layers 
were soaked in transblot buffer and the blot was set up the following way (bottom 
to top): three layers of Whatman paper, one layer of nitrocellulose membrane, the 
gel containing the protein(s) of interest, 3 layers of Whatman paper. The set up was 
transferred into a semi-dry blotting apparatus and power was applied at 20 V for 
20 min. To confirm successful blotting and, in cases where no pre-stained protein 
marker was used, in order to mark the protein ladder, the membrane was stained 
with Ponceau S solution, which provides a method for unspecific, rapid, reversible 
protein staining. Thereafter the membrane was completely destained with H2O and 
for blocking transferred into a bath containing 5 % milk powder in 1x TBS-T. 
Blocking was done at 4° C overnight while gently shaking.  
2.2.5.7.2. Detection of the protein of interest 
After blocking the membrane was put into 1x TBS-T for approx. 10 min. Thereafter 
the TBS-T was poured away and the membrane was incubated for 1 h at room 
temperature with 15 ml of the α-His HRP conjugated antibody solution (see also 
section 2.1.8.). Subsequently the antibody solution was removed (but could be kept 
for reuse) and the membrane was washed 3 x 10 min with 1x TBS-T. Antibodies 
bound to the proteins on the membrane were detected by the using the ECL kit 
from PIERCE according to the manual. Upon that the membrane was put into an 
exposure cassette. In the darkroom an X-ray hyper film (Amersham Biosciences) 
was placed over the membrane and exposed (the optimal exposure time was 
determined by trial and error). After development of the film, bands became visible. 
2.2.6. Bandshift assays 
Concentration of DNA to be shifted was determined using a NanoDrop ND-1000 
from Peqlab. Protein concentration was determined by comparison with designated 
BSA standards of known concentration in an SDS-PAGE gel.  
  
Materials & Methods 
76 
Molarity of DNA or protein concentration, respectively was calculated using the 
following formulas: 
𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝐷𝐷𝐷𝐷𝐷𝐷 = µ𝑔𝑔 𝐷𝐷𝐷𝐷𝐷𝐷 × 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝660 𝑝𝑝𝑔𝑔 × 106 𝑝𝑝𝑔𝑔1 µ𝑔𝑔 × 1𝐷𝐷 
(N being the number of nucleotides) 
𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 = µ𝑔𝑔 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝
𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑠𝑠𝑝𝑝𝑠𝑠𝑝𝑝 (𝑘𝑘𝐷𝐷𝑘𝑘) × 𝑘𝑘𝑔𝑔109 µ𝑔𝑔 × 1012 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝  
 
Bandshift reactions were set up in an Eppendorf tube as follows:  
 x µl protein solution 
 x µl DNA 
 x µl* 5x GBB (DTT freshly added) 
 2 µl BSA (1 mg/ml) 
 ad 20 µl ddH2O 
 
*Within the batch the dilution of GBB is 1x. The volume of 5x GBB to be added depends on 
the volume of protein added, since the protein is dissolved in 1x GBB buffer.   
Reactions were incubated at 37° C for 1 h. Thereafter 5 µl of 5x Orange G loading 
dye were added and the total volume of the reaction (25 µl) was loaded onto an 
agarose gel (agarose molten in band shift running buffer). The gel was run in 
bandshift running buffer while applying relatively low voltage of approx. 5 V/cm. 
After running the gel was stained with ethidium bromide as previously described 
and bands were visualized under UV light. 
2.2.7. Structure prediction of gp49 
For computational structure prediction of gp49 the amino acid sequence 
(nu. 34480 – 34833 of the φCh1 genome) was sent to the PHYRE server for analysis 
(Kelley & Sternberg, 2009).  
Disorder prediction  of gp49 was carried out by sending the respective sequences to 
the web based application DISOPRED2 provided by the Bioinformatics Unit at the 
Department of Computer Science at the University College, London (Ward et al., 
2004).  
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3. Results & Discussion 
3.1. Further analysis of the φCh1 replication region 
The analysis of the φCh1 replication region culminated in the development of the 
pRo-5 shuttle vector system (see also section 1.2.2.5.). However, in order to obtain a 
more complete picture of the φCh1 replication further research had to be done, as 
some questions remained to be answered. In addition to that, there were some 
assumptions that had to be proven experimentally. This was done in the present 
work. 
3.1.1.  Introduction of +1 frameshift mutations into ORF53 and 
 ORF54  
As mentioned previously sequence analysis revealed high similarities of both 
ORF53 and ORF54 with the repH gene of H. marismortui. If cloned onto a pKSII+ 
vector together with a novobiocin resistance marker it is possible to transform this 
plasmid into Nab. magadii. Further experiments with respect to the φCh1 
replication region had shown, that if the start-codons of the 3´ and 5´ flanking 
ORFs (ORF49 and ORF55, respectively) are deleted, the transformation efficiency 
of the resulting vector increases dramatically (see also section 1.2.2.5.).  
However, as all shuttle vectors of the pRo – series that had been constructed so far 
(pRo-1 to pRo-6) always contained the fully functional repH homolog comprising 
both ORF53 and ORF54, the assumption that both ORFs are really necessary for 
replication had to be confirmed experimentally. Therefore frameshift mutations 
were introduced into ORF53 and ORF54 by PCR and the respective fragments 
were finally cloned onto the pNov-1 plasmid thus giving rise to two new shuttle 
vectors, pRo-8 and pRo-11, respectively. Both of which are identical to the 
functional pRo-5 vector except from carrying a +1 frameshift mutation either in the 
ORF53 (pRo-8) or in the ORF54 (pRo-11) in order to render the respective ORF 
inactive.  
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3.1.2. Deletion of up- and downstream palindromic sequences  
The repH homolog of φCh1, comprising ORFs 53 and 54, is flanked by palindromic, 
AT-rich sequences. Previously it has been shown by Ng and DasSarma, that at 
least the 5´ AT-rich sequence is required for the minimal origin of replication in the 
Hbt. salinarium plasmid pNRC-100 (Ng & DasSarma, 1993). Thus the question 
arose whether this would also be true for the φCh1 origin of replication. 
Additionally, as there is also a 3´ AT-rich sequence it was only reasonable to take a 
closer look to it as well. In order to further elucidate the role of these two 
palindromic sequences three different constructs, i.e. shuttle vectors were created. 
One of which, pRo-7, does no longer contain the 5´ palindromic sequence whereas 
pRo-9 is deprived of the 3´ AT-rich region. In addition to that pRo-11 lacking both 
palindromic sequences was also constructed. All deletions were created by PCR.  
 
Figure 6| The pRo cloning series. The picture shows a schematic representation of the 
φCh1 origin of replication together with the corresponding homologous region of 
H. marismortui plasmid pNRC100 repH. The two palindromic sequences flanking 
ORF53/ORF54 are indicated by opposing arrows. To study this region in φCh1 different 
fragments of it were cloned into a pKSII+ vector and transformation efficiency of Nab. magadii 
transformed with the respective resulting vectors was analyzed. This led to the development of 
the pRo-5 plasmid by Iro et al., a fully operational Nab. magadii shuttle vector. It lacks the 
starting codons of two ORFs (49 and 55) involved in gene regulation of φCh1 (Iro et al., in 
prep.). In this thesis the derivates pRo-7 – pRo-11 were developed in order to further 
characterize the origin of replication. pRo-7 and pRo-9 are lacking the 5´ and 3´ palindromic 
sequences, respectively, while pRo-10 is lacking both at the same time. pRo-8 carries a +1 
frameshift mutation (indicated by asterisks) in ORF53 whereas the same is true for ORF54 in 
pRo-11. 
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3.1.3.  Transformation of pRo-5 derivates into Nab. magadii 
All of the constructed vectors (pRo-7 to pRo-11) were transformed into Nab. 
magadii L13. As a positive control, pRo-5 was used. Thus (i) it was confirmed, that 
Nab. magadii cells were competent at the timepoint of transformation and (ii) the 
“normal” transformation efficiency could be determined and correlated with that of 
the other constructs. As a negative control Nab. magadii L13 competent cells not 
transformed with a vector (but with an equivalent volume of spheroblast solution) 
were taken.  In order to achieve comprehensive comparability between all 
experiments the used amount of vector DNA was always 3 µg in total. After 
incubation colony forming units (cfu/ml) were determined and correlated to each 
other. In order to obtain statistically relevant data each experiment was done in 
triplicates for each batch. Additionally each batch was plated on three agar plates 
and the total experiment was repeated at least three times (only statistically 
relevant data sets were used for calculation of cfu/ml).  
3.1.4. Discussion 
Concerning the transformation efficacy the inactivation of ORF53 and ORF54, 
respectively, shows an unambiguous result. Cultures transformed with shuttle 
vectors carrying one of the two frameshift mutations (pRo-8 and pRo11) are not 
able to grow on novobiocin suggesting that the vector can no longer be replicated 
within Nab. magadii. These facts lead to the conclusion, that both ORF53 as well 
as ORF54 are vital for plasmid replication and in the broader sense crucial for 
φCh1 propagation. Furthermore this is in accordance with previous findings of Ng 
et al.. identifying repH of plasmid pNRC100 as crucial element for a minimal origin 
of replication in Hbt. salinarium (Ng & DasSarma, 1993). However, these findings 
are not unexpected given that the virus φH infecting Hbt. salinarium has been 
shown to exhibit a similar gene arrangement of its replication origin as φCh1 
(Klein et al., 2002) and is the closest relative to φCh1, sharing up to 97 % sequence 
identities (Klein et al., 2002) over large parts of their genomes. As a conclusion one 
can say, that in the case of φCh1 infecting Nab. magadii two open reading frames 
mediate RepH activity. Yet this statement immediately leads to the question why 
there are two separate ORFs involved. As both ORFs eventually give rise to two 
distinct proteins, it seems possible, that they act as a heterodimer. On the other 
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hand both proteins could perform distinct actions. Effort has been taken to identify 
a possible binding site of either gp53 or gp54 on the φCh1 genome. Here the two 
flanking palindromic sequences upstream of ORF53 and downstream of ORF54 
seem to be the most likely sites. Such interactions have been shown to occur in 
other systems, where binding of certain proteins to the DNA results in a melted 
replication complex, additionally supported by AT-rich regions (Schnos et al., 1988; 
Kornberg & Baker, 1992; Ng & DasSarma, 1993). However, all attempts 
confirming this for φCh1 gp53/gp54  have so far not been crowned with success 
which is probably less due to the fact that there is no interaction rather than to the 
difficulties that accompany the work with halophilic proteins.  
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Figure 7| Transformation efficiency of pRo derivates. Nab. magadii L13 was 
transformed with different constructs of the pRo cloning series, plated on selective agar and 
colony forming units (cfu) per ml were determined. All pRo -plasmids contain fragments of the 
φCh1 origin of replication (see also Figure 6). The pRo-5 vector is used as the standard shuttle 
vector in the lab of A. Witte and serves as a control, along with untransformed L13 cells. When 
a +1 frameshift mutation is introduced into either ORF53 (pRo-8) or ORF54 (pRo-11) nearly no 
viable colonies are observed. This confirms the assumption that in φCh1 two ORFs rather than 
one mediate RepH activity. If the 5´ palindromic, AT-rich sequence flanking ORF53 is 
removed, the transformation efficacy decreases (pRo-7) by ~33 %. In the case of pRo-9, where 
the 3´ palindromic sequence flanking ORF54 has been removed the transformation efficacy is 
reduced by ~82 %, suggesting that the 3´ AT-rich sequences are more important. Surprisingly, 
if both the 5´ as well as the 3´ sequences are removed, as is the case for pRo-10 the 
transformation efficacy is nearly restored.  
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The analysis of the AT-rich palindromic sequences themselves delivered somewhat 
surprising results. If deprived of the 5´ flanking region of ORF53 the shuttle vector 
shows a significant reduction of the transformation efficiency. However, the degree 
of this decrease is less dramatic than expected since Ng and DasSarma described a 
total loss of replication ability when they deleted the 5´ AT-rich sequence of repH 
(Ng & DasSarma, 1993). Nonetheless, the deletion of the 3´ palindromic sequence 
of ORF54 gave results comparable to that of Ng and DasSarma (Ng & DasSarma, 
1993). Although no total abolishment of replication ability could be observed the 
transformation efficacy is dramatically reduced. These findings suggest the 3´ AT-
rich sequence rather than the 5´ sequence plays a key role in φCh1 replication. 
These results however are most surprisingly and completely unexpectedly 
contradicted as the deletion of both palindromic sequences nearly restores the wild 
type. For pRo-10 one would expect at least a transformation efficiency in the range 
of pRo-9 rather than pRo-5. This result questions the importance of both AT-rich 
regions in φCh1 as a whole but would on the other hand provide an admittedly 
sparse explanation for the fact, that so far no interaction of gp53 or gp54, 
respectively, with any of these palindromic sequences could be found. Thus the 
relevancy of these regions could have been simply overestimated. Yet the deletion 
of only one of these sequences has an undeniable effect on the transformation 
efficiency so that it seems absurd to assume that they are of no significant 
importance. In addition to that in the pRo-5 vector the φCh1 ori has been reduced 
to a minimum that would give an operational origin of replication. In other words 
there is not much left in all the shuttle vectors that gp53 and gp54 could interact 
with.  
  
Results & Discussion 
82 
3.2. Characterization of ORF49 
3.2.1. Gp49 acts as φCh1 repressor 
In previous studies the gene product of ORF49 of φCh1 has been suggested to be 
involved in the switch between the lysogenic and the lytic life cycle of the 
virus (Iro et al., 2007). The present work contributed in the further elucidation of 
the gp49 activity. Prior to this work the ORF49 of φCh1 including its promoter has 
been cloned onto the pRo-5 shuttle vector (Meissner, 2008). Furthermore in 
addition to the pRo-5 shuttle vector the plasmids pRo-4 and pRo-6 were also 
available (Ladurner, 2008). Both plasmids carry a fully operational copy of the 
ORF49. However in comparison to pRo-4 the pRo-6 vector has the starting AUG of 
ORF55 deleted. The latter modification is vital for a high transformation efficiency 
of the pRo vectors in Nab. magadii (refer also to section 1.2.2.5.). In order to 
investigate the effect of gp49 on the infectivity of φCh1 a phage titer analysis was 
performed. Nab. magadii L13 cells transformed with the vectors pRo-4, pRo-5,  
pRo-6 and pRo-5-ORF49, respectively were infected with previously isolated virus 
particles and the titer was determined by the soft plating technique. An 
untransformed Nab. magadii L13 strain served as a control and for determination 
of the titer of the stock. The experiment was done in duplicates and after approx. 2 
– 3 weeks the plaques were counted. The results are depicted in Figure 8 and show 
a dramatic effect of ORF49 on the infectivity of φCh1. In comparison to the normal 
titer for cells carrying pRo-5-ORF49 plaque formation is reduced by a factor of 
approx. 1.1 x 104. Cells that had been transformed with pRo-5 show no significant 
deviations from the normal titer since in the pRo-5 vector ORF49 is deleted for its 
start codon. On the other hand, pRo-6, carrying a fully operational ORF49, shows a 
decrease in phage infectivity which is as dramatic as it is for pRo-5-ORF49. 
However, cells that were transformed with pRo-4 behaved like normal Nab. 
magadii L13 cells. This was a little bit surprising as pRo-4 also contains a fully 
functional ORF49. Consequently ORF55, which is intact on pRo-4 but not on pRo-6, 
must be responsible for the restoration of the normal titer. One possible 
explanation for this is that because pRo-4 carries the fully operational ORF55 the 
ability for replication of the vector itself is reduced and thus gp49 is simply diluted 
over the time. Indeed, former studies have shown that the transformation 
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efficiency of pRo-4 is much lower than that of pRo-5 (Ladurner, 2008). 
Nevertheless, this effect might be too weak to solely account for the restoration of 
the normal titer. As a matter of fact ORF55 has been shown to share sequence 
similarities to known regulators (Klein et al., 2002; Iro et al., in prep.) so that it is 
likely to play a more active role in the regulation of the phage life cycle. This 
assumption is supported by the present work. However in order to fully elucidate 
the function of ORF55 further studies on this subject will have to be carried out.  
Nonetheless, the above described experiment made it obvious that gp49 has a 
strong repressor activity on its own. This is also in accordance to the findings of Iro 
et al. (Iro et al., 2007) where a regulatory effect of the known repressor ORF48 (rep) 
on ORF49 was shown. If expressed extra-chromosomally from a plasmid gp49 
severely reduces lysis of φCh1 infected Nab. magadii L13 cells.  
 
  
Figure 8| Repressor Activity of gp49. Phage titer analysis with different strains of L13 that 
have been transformed with certain vectors of the pRo series (see also Fig. 6). The normal titer 
is represented by L13 infected with φCh1. The pRo-5 shuttle vector, where gp49 has been 
deleted for its starting AUG, shows no differences to the normal titer. On the other 
hand pRo-6, carrying the same sequence as pRo-5 but in addition also an intact gp49, shows a 
dramatic reduction of the titer. If cloned into a pRo-5 vector ORF49 dramatically reduces the 
pfu/ml, suggesting that gp49 is able to solely account for repression of the phage. However, 
pRo-4 shows a surprising result, as it carries a fully operational ORF49 but seems not to 
repress phage activity at all. One explanation might be the additional ORF55 in comparison to 
pRo-5. ORF55 is thought to be involved in φCh1 regulation. 
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3.2.2. Putative 3D structure of gp49 – an attempt in silico 
The “protein homology/analogy recognition engine” (PHYRE) provides a powerful 
tool for protein structure prediction (Kelley & Sternberg, 2009). Besides the 
common iterative PSI-Blast search for homologies one of its features comprises the 
comparison of the amino acid sequence of the protein of interest to known protein 
structures available in databases. Thus the 3D structure prediction gains on 
accuracy. This was also done with the sequence of ORF49 (nu. 34480 – 34833 of the 
φCh1 genome). The output of the PHYRE query gave a couple of different models 
for the predicted 3D structure of gp49. Disappointingly, yet not unexpectedly, the 
estimated precision of the calculated models is very low. This is probably due to the 
fact that present databases contain relatively few archaeal protein structures in 
general. Thus the highest score with an estimated precision of 5 % showed some 
homologies to a eukaryotic enzyme – the monoclinic mimivirus capping enzyme 
triphosphatase (Benarroch et al., 2008). Nonetheless, it should be mentioned that 
among all calculated 3D structures one prediction is reminiscent to a protein 
named Tat, which is involved in transcription regulation (Sticht et al., 1994). The 
results of the secondary structure prediction of gp49 by PHYRE are depicted in 
Figure 9 together with some 3D structure predictions. However, it is obvious that 
these predictions are very unlikely to match the reality. As a matter of fact there 
are apparently too few (archaeal) protein structures available in the current 
databases to ensure a reliable structure prediction for gp49.  
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In addition to the 3D structure a prediction for disordered residues was also carried 
out. This was done with the DISOPRED2 server according to Ward et al. (Ward et 
al., 2004). Disordered regions do not per se have a native conformation into which 
they fold rather than being intrinsically unstructured. This disorder can be local or 
global and for the former it has been shown that such regions can be biologically 
active (Wright & Dyson, 1999). The results are depicted in Figure 10 and show 
predicted disordered regions at the N-terminal, as well as at the C-terminal end of 
gp49. 
b c 
a 
Figure 9| Structure predictions of gp49. a| Secondary structure predicted by PHYRE. The 
“Cons_prob” row illustrates the confidence of the consensus prediction, that is used for tertiary 
structure prediction (0=low confidence; 9=high confidence). The letter “e” indicates amino acids 
predicted to fold into β-sheets whereas “h” stands for amino acids that fold into a helix. The 
overall confidence of structure prediction is relatively low since too few archaeal protein 
structures are currently available in public databases. b| The tertiary structure prediction 
with the highest estimated precision of 5 % is shown here. It is reminiscent of the monoclinic 
mimivirus capping enzyme triphosphatase (Benarroch et al., 2008) with a sequence identity of 
19 %. c| At least one of the structures predicted by PHYRE shows similarities to a protein 
named Tat which is involved in transcriptional regulation (Sticht et al., 1994).  
(Structure predictions were done with PHYRE (Kelley & Sternberg, 2009) and molecular 
graphics images were produced using the UCSF Chimera package from the Resource for 
Biocomputing, Visualization, and Informatics at the University of California, San Francisco 
(supported by NIH P41 RR-01081) (Pettersen et al., 2004). 
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a 
b 
Figure 10| Intrinsic disorder prediction for gp49. a| Prediction of disordered residues 
within the primary sequence of gp49. Numbers in the upper line indicate the confidence of the 
computer prediction (9 = high confidence). The N-terminal as well as the C-terminal end of 
gp49 probably contain disordered regions. Such regions are likely to exist in an unfolded state 
within the cell. b| Schematic representation of the disorder probability of amino acid residues 
within gp49.  
(Predictions were done with the DISOPRED2 server according to Ward et al. (Ward et al., 
2004)) 
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3.2.3. Overexpression of ORF49 in E. coli sp. 
In order to purify gp49 in sufficient amounts it had to be overexpressed 
heterologous in E. coli. Therefore ORF49 was cloned onto the pRSETA plasmid, an 
expression vector commercially available from Invitrogen that carries the T7 
promoter to ensure strong expression of the protein of interest. This was done for 
gp49 in order to make the purification of the protein as well as its identification 
more convenient.   
 
The vector was then transformed into different E. coli strains (Tuner, Rosetta, 
BL21, C41 and C43) to find the most suitable strain for expression. Surprisingly, 
sufficient expression of gp49 could only be observed in E. coli BL21 pLysE but not 
in Rosetta, though both strains are extremely closely related. The best time point 
for harvesting expressing cells was determined to be 3 – 5 h after induction with 
Figure 11| Overexpression of gp49. Crude extracts taken from two different E. coli strains 
that had been transformed with pRSETA-ORF49. Extracts where taken at different time 
points before and after induction with 0.5 mM IPTG (tmin= minutes after inoculation (before 
induction); timin= minutes after induction). Arrows indicate the expected height for gp49. 
a|E. coli Rosetta shows, if any, a minimal expression of gp49 60 min after induction. The 
expression level stays nearly the same over the observed amount of time. b| In contrast to that 
E. coli Bl21-pLysE shows an increasing expression of gp49 with a maximum 4 h after 
induction. However, upon an expression over night the protein is degraded.   
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IPTG. If expressed overnight gp49 is no longer detectable in a PAA gel probably 
due to degradation.  Expression of gp49 was confirmed by Western blot analysis 
using α-His antibodies. The results of the overexpression are shown in Figure 11. 
In order to find a way to purify gp49 natively ORF49 was cloned additionally into 
the pMal-c2X vector which fuses a maltose tag to the protein of interest (see also 
section 3.2.4.). This vector was cloned into E. coli BL21 and overexpression of the 
fusion protein was monitored by SDS-Page. Again the best time point for 
harvesting cells was 3 – 5 h after induction with IPTG. Yet again as described 
above upon induction overnight the protein was no longer detectable in a PAA gel.  
3.2.4. Purification of gp49 
In order to use gp49 for bandshift assays it had to be purified from E. coli first. For 
such an assay to work it is further necessary that the purified protein retains its 
native conformation and folding. Therefore purification under native conditions is 
desirable. A native purification was attempted in the first place with gp49 that had 
been cloned into pRSETA (see also section 2.2.5.2.) but could never be achieved and 
did not show any detectable results although overexpression of the protein gave 
massive amounts of protein seen in an SDS-Page gel when E. coli BL21 crude 
extracts were analyzed (see Figure 11b and 12a). This suggests that gp49 when 
expressed from a T7 promoter and carrying an N-terminal 6x His tag is either 
insoluble or aggregates in insoluble inclusion bodies within the host cell. This was 
confirmed when a direct purification of the inclusion bodies that was performed 
resulted in massive amounts of purified gp49. In order to reduce inclusion body 
formation different growth temperatures were tested as well. As lower 
temperatures result in slower growth of E. coli and should hence reduce formation 
of inclusion bodies it was attempted to grow the cultures at 28° C as well as at 
16° C. These attempts were unsuccessful though, as no soluble protein could be 
detected.  In a last attempt to isolate gp49 natively it was purified from E. coli Bl21 
that has been transformed with the pMal-c2X-ORF49 vector carrying a maltose 
tag. Using this plasmid purification of the fusion protein under the previously 
described native conditions was possible. However, the obtained protein fractions 
seemed to be extremely impure, unsuitable for bandshifting experiments.  
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For all of the above described reasons native purification of gp49 was abandoned 
and exchanged by purification under denaturing conditions with 8 M urea using 
the vector pRSETA. 
In contrast to the native purification this worked extraordinary well as Figure 12b 
depicts. Yet it raised another problem as denatured proteins are of no use in a 
bandshift assay. Therefore several methods for renaturing the protein were tested. 
(i) Dialysis provides an easy and convenient way to get rid of denaturing agents but 
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Figure 12| Purification of gp49. Capital letters indicate the different fractions of affinity 
chromatography (F=Flowthrough, W=Wash, E=Elution) a| Native purification using Ni-NTA 
agarose to isolate His-tagged gp49 failed. No bands on the correct height of around 18 kDa are 
visible in a coomassie stained PAA gel. b| Denaturing purification of His-tagged gp49 using 
8 M urea reveals massive amounts of gp49 visible in the PAA gel. The fact that denaturing 
purification worked that well while native attempts remained unsuccessful suggests that gp49 
aggregates into insoluble inclusion bodies within the cells. c| A Western blot using α-His 
antibodies confirms that the purified protein is indeed gp49. 
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although at least two dialysis steps were performed (see also section 2.2.5.5.2.) 
gp49 always precipitated when the concentration of urea was reduced to less than 
4 M. Thus it seemed that dialysis was unsuitable for removing the denaturing 
agents. (ii) A promising method for renaturing the protein was to cut it out from a 
PAA gel. This additionally provided another purification step as exactly the band of 
interest can be used. This was done with a kit obtained from Fermentas and the 
protocol included an electrophoresis step combined with a dialysis step followed by 
precipitation of the protein with trichloroacetic acid (TCA). However, though this 
method was repeated several times isolation of gp49 worked only once. For this 
reason and for the fact that an additional denaturing step (TCA precipitation) is 
involved the method of eluting gp49 from a PAA gel was abandoned as well. (iii) In 
order to test another simple method for renaturation – rapid dilution – the 
inclusion bodies containing gp49 were directly purified from E. coli. Thereafter one 
batch was solubilized using 8 M urea and another one using 6 M guanidine 
hydrochloride (GuHCl). Thus protein solutions with a concentration of 5 mg/ml and 
1 mg/ml respectively were created. These were simply diluted into a relatively 
large volume of buffer containing no urea or GuHCl. However, this did not work as 
the volume of native buffer in which the protein no longer precipitated was too 
large to give a reasonable concentration of gp49 suitable for bandshifting.(iv) 
Finally, renaturation using size exclusion chromatography, i.e. gel filtration, gave a 
satisfactory yield of gp49 solubilized in a buffer containing no denaturing agents.   
3.2.5. Bandshifit assays (EMSA) 
In order to identify the binding region of gp49 within the φCh1 DNA a series of 
electrophoretic mobility shift assays (EMSAs), i.e. bandshift assays, were 
performed. In general this method is based on the altered migration behavior of 
DNA bound to protein in comparsion to free DNA in an agarose gel. 
3.2.5.1. Bandshifting of total φCh1 DNA and fragments 
In a first attempt viral DNA from φCh1 was isolated and digested with BglII giving 
24 fragments including the non digested, methylated fraction. Thereafter the 
digested DNA was incubated together with rising concentrations of purified and 
renatured gp49. Subsequently the batches were loaded onto an agarose gel. The 
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results are shown in Figure 13. Most obvious is that upon addition of very high 
concentrations of gp49 the migration of the larger fragments is drastically slowed 
down leading to distortions of the respective lanes. Nonetheless at least two shifts 
are visible on the gel. One affects a fragment that ranges around 3.6 kb (the F1,2 
fragment) and another one occurs in a fragment that is out of the range of the 
marker at approx. 11 kb (the A fragment). Unfortunately, although the experiment 
was repeated several times, these results could not be reproduced.  
 
Subsequent to this experiment other φCh1 DNA fragments were directly tested. 
These had been previously cloned into several vectors in the lab of A. Witte by R. 
Klein. The respective fragments were cut out of their vectors and purified. In 
addition to that two fragments were generated by PCR, the F1 fragment as well as 
the p17-5/21-Hind fragment (according to the primers used for its generation). All 
these fragments were incubated together with renatured gp49 to see whether they 
would shift or not. The result is depicted in Figure 14a, b. Disappointingly, there is 
no convincing shift visible on the gel. Yet, the I/9 fragment as well as the F1 digest 
and the p17-5/21-Hind digest show, though little, shifts. In contrast to that the 
Figure 13| Electrophoretic mobility shift assay (EMSA) using total φCh1 DNA. The 
DNA was isolated from the virus and digested with BglII giving 24 fragments. Thereafter DNA 
was incubated with different concentrations of purified gp49 that had been renatured by gel 
filtration. A λ:BstEII digest serves as a marker. The highest concentrations of gp49 result in 
massive distortions of the upper part of the respective lanes. At least two different shifts are 
visible. One of these shifts ranges around 11 kb, the other at around 3.6 kb (indicated by 
arrows). 
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control, which contains linear pKSII+ DNA does not show any shift. In addition to 
that the BSA control does also show no shifts of any of the fragments. 
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Figure 14| Bandshift assay with selected φCh1 DNA fragments. The φCh1 fragments 
have been previously cloned by R. Klein (Klein, 1999). Plasmids were isolated  from E. coli 
XL1 – Blue (asterisks mark fragments isolated from E. coli GM48F´) and fragments were cut 
out of their respective vectors. EMSAs were performed using 400/600 nM of gp49 that have 
been purified and renatured by gel filtration. The same concentrations of BSA were used as a 
control. A λ:BstEII digest serves as a marker. a| No convincing shifts are visible with these 
fragments. b| Shifts can be observed with the fragments I/9, F1 and p17-5/21-Hind. Here both 
concentrations of gp49 seem to result in a small shift of the respective fragments, while the 
BSA controls do not shift. Linearized pKSII+ DNA does also show no shift at all. 
a 
b 
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3.2.5.2. Bandshifting selected φCh1 ORFs and DNA fragments 
As the first bandshift assays gave only moderate results strategies were changed. A 
number of selected φCh1 ORFs suspected to be involved in the regulation of the 
phages life cycle were directly tested. The second change in the experimental 
procedure was to no longer try to fully renature gp49. The protein was dialyzed 
only to 4 M urea after it has been purified under denaturing conditions (using 8 M 
urea). Under these conditions it remained soluble. This alteration made the whole 
assay simpler by reducing the steps of renaturation.  
The first ORFs to be tested were ORF43 and ORF44, since these ORFs were shown 
to be involved in the gene regulation of φCh1 as enhancing elements for 
the ORF48 – ORF49 intergenic region that contains at least two promoter elements 
(Iro et al., 2007). Surprisingly, the very first experiment of this series, in which the 
PCR generated ORF43 DNA was used already showed shifts and is depicted in 
Figure 15a. However, unfortunately the control DNA, which is the CRISPR 
sequence from Strp. pyogenes also showed a comparable shift. On the other hand 
shifting ORF43 with BSA solubilized in 4 M did not work under the same 
conditions (Figure 15b). In another experiment the influence of methylation on 
binding was studied when the PCR generated ORF43 was compared to the 
ORF43/44* fragment that had been cloned into a pKSII+ vector prior to this work 
(Iro, 2006). This way it could be shown, that methylation does not affect binding of 
g49 (Figure 15c,d).  
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Figure 15| EMSA – testing gp49 on ORF43. Gp49 was purified under denaturing conditions, 
dialyzed to 4 M urea and used to shift the DNA of φCh1 ORF43. Numbers indicate the molar 
ratio of DNA to protein. a|Three different isolates of gp49 (a,b,c) where initially tested on 
ORF43 DNA that had been generated by PCR. The CRISPR sequence of Strp. pyogenes was 
used as a control. Both sequences have a comparable length of approx. 500 bp and seem to be 
shifted in the presence of gp49. Shifts appear at a height of approx. 3.7 kbp. b| Control proving  
that gp49 is responsible for the shifts. Equal concentrations of BSA dissolved in 4 M urea do 
not induce a shift in ORF43 DNA. c, d| Methylation of DNA does not affect the shifts. Non 
methylated DNA of ORF43 was generated by PCR while methylated ORF43 was obtained from 
from E. coli XL1-Blue where it had previously been cloned into a pKSII+ vector (Iro, 2006). 
However the DNA isolated from the plasmid is a little longer resulting in higher shifts at 
approx. 4.5 kbp. 
a b 
c d 
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To confirm, that the above observed shifts are not unspecific the binding of gp49 to 
the intergenic region of ORF48 and ORF49 was tested. Therefore two fragments of 
different lengths were created by PCR: (i) the prom-1/prom-2 fragment with a 
length of 579 bp and (ii) the 1082 bp prom-2/prom-3 fragment. Unexpectedly both 
fragments did also show a shift as depicted in Figure 16. In a last attempt gp49 
was tested against the region of the Nab. magadii methyltransferase, where it 
definitely should not bind to. Again the fragment was generated by PCR using the 
primers N6-1b/MT-RT-I1 but there also a shift could be observed. These 
observations lead to the conclusion that binding of gp49 to DNA is of an unspecific 
nature under the applied conditions.   
 
3.2.5.3. Comparison of gp49 wt and 3´ deletion mutants 
In order to answer the question where the gp49 DNA binding domain is located C-
terminally truncated versions of the protein were created. Subsequently the 
Figure 16| EMSAS with unspecific DNA. Gp49 was purified under denaturing conditions 
and dialyzed to 4 M urea. DNA used for these assays was generated by PCR. Numbers indicate 
the molar ratio of DNA to protein. a| Unexpectedly besides the ORF43 DNA gp49 is also able 
to shift a 580 bp long  part of the φCh1 methyltransferase region which has been obtained by 
PCR. This fragment is shifted to a height of approx. 2.8 kbp. b| Gp49 is also able to induce a 
gelshift with DNA from the intergenic region of ORF48 and ORF49. Two fragments of different 
sizes were generated, one of which with a length of 1082 bp is shifted to approx. 10 kbp. The 
other fragment with 579 bp in length is shifted to approx. 5.8 kbp.  
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truncated gp49 derivatives together with the wild type protein were tested for 
bandshift activity on φCh1 ORF43 DNA. Surprisingly all of the deletion mutants 
seem to shift equally well. Even the shortest version, gp49Δ5 which consists of only 
57 of the native 118 codons is able to induce a gelshift equal to the wild type 
protein (Figure 17b, c). 
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Figure 17| Comparison of gp49 wt and truncated versions on ORF43 DNA. 
a| Schematic representation of the ORF48 – ORF49 region on the φCh1 genome showing the 
different constructs used in this assay. Each mutation being shorter than the former one by 
approx. 30 – 40 nucleotides. The fragments were each cloned into a pRSETA expression vector 
and the respective gp49 derivatives were purified under denaturing conditions using 8 M urea. 
Thereafter proteins were dialyzed to 4 M urea. Subsequently the proteins were used to shift 
φCh1 ORF43 DNA  obtained by PCR. b| No difference  in the shifts is visible between gp49 wt 
and gp49Δ1. c| The same is true for deletions Δ2, Δ4 and Δ5. Unfortunately gp49Δ3 could not 
be purified in sufficient amounts for testing. However, evidence is strong that Δ3 also would 
give an equal shift as gp49 wt.  
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3.2.5.4. Comparison gp49 wt and N-terminal deletion 
Since all of the C-terminally truncated versions of gp49 seemed to be able to shift 
DNA an N-terminal deletion mutant of gp49, gp49ΔN, was constructed in order to 
compare its binding affinity to that of wild type gp49. Gp49ΔN was deleted for the 
first 52 codons in comparison to the wild type. Both proteins were purified under 
denaturing conditions as before and then tested on the ORF43 DNA generated by 
PCR that has been shown to give a clearly detectable shift. This bandshift assay is 
depicted in Figure 18. While gp49 shifts the DNA as observed previously the 
mutant form does not seem to induce such a shift. Taken together with the results 
from the experiments with the C-terminal truncations (see above) this suggests 
that the DNA binding domain of gp49 is located N-terminally rather than C-
terminally.  
 
  
Figure 18| Comparison of gp49 and gp49ΔN. Both proteins were purified under denaturing 
conditions and thereafter dialyzed to 4 M urea. Subsequently they were used for bandshift 
assays with φCh1 ORF43 DNA that had been generated by PCR. The numbers indicate the 
molar ration between DNA and protein. Gp49 wt does induce a gelshift as before which 
becomes clearly visible at a molar ratio of 1:250. On the other hand no reaction can be observed 
when gp49ΔN is used suggesting that the binding domain of gp49 is located at the N-terminal 
end of the protein.  
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3.2.6. Construction and analysis of 5 different deletion mutants of 
ORF49 
To further elucidate the characteristics of gp49 deletion mutagenesis was used. 
Using the sequence of ORF49 five derivates (ORF49Δ1 – ORF49Δ5) with 
truncated 3´ ends were generated by PCR. Each fragment subsequently being 
shorter than the former one by approx. 30 – 40 nucleotides (for exact values refer to 
section 2.1.4.).  
 
The thus obtained fragments were then cloned into the pRo-5 shuttle vector and 
subsequently transformed into Nab. magadii. Thereafter single colonies were 
taken and used for inoculation of selective medium. These liquid cultures were 
later infected with φCh1 particles and plaques were counted. The result is 
unambiguous as Figure 19 clearly depicts. While mutants ORF49Δ1 – Δ3 seem to 
Figure 19| Repressor activity of gp49 C-terminal deletion mutants. 5 different deletion 
mutants of ORF49 were generated, each being subsequently truncated by approx. 30 – 40 
nucleotides. This mutants ORF49Δ1 – ORF49Δ5 were cloned into the pRo-5 shuttle vector and 
transformed into Nab. magadii L13. Strains obtained this way were infected with φCh1 virus 
particles and titers were determined. The data show that while mutants Δ1 – Δ3 are equally 
potent to repress plaque formation as the wild type ORF49Δ4 and ORF49Δ5 seem to have lost 
their repressor activity. 
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be fully functional concerning their repressor activity ORF49Δ4 and ORF49Δ5 have 
lost their ability to repress plaque formation. Hence the crucial region for gp49 
activity is located in the codons 1 – 81 from altogether 117 codons. 
3.2.7. Discussion 
The data gathered by this work clearly underline the assumption that gp49 is 
indeed a repressor of φCh1. It also gives some hints on the nature of this 
repressing function. Although 3D structure prediction only marginally supports the 
suggestion that gp49 is a DNA binding protein (but at the same time does not 
exclude it), the performed EMSAs show a different picture.  
The purification of gp49 in a way that it remains its native structure from the 
beginning to the end was shown to be extraordinary difficult and could not be 
achieved with the disposable means. Heterologous expression of gp49 in E. coli sp. 
led to the formation of insoluble inclusion bodies and no soluble form of gp49 could 
be detected using methods for native protein isolation. Inclusion body formation 
seemed to be independent from the used E. coli strain as well as the growth 
temperature. On the other side the denaturing purification of the inclusion bodies 
containing gp49 does not only have disadvantages. In many cases the expression 
level of the heterologous protein can reach up more than 30 % of the total cellular 
protein (Singh & Panda, 2005). Additionally inclusion bodies can be isolated very 
simply and they contain the accumulated protein of interest in a relative pure form 
(Singh & Panda, 2005). However, the renaturation of a protein of unknown 
function holds certain biases as a successful restoration of the protein´s active form 
cannot be confirmed by an assay testing its function. This problem is reflected by 
the attempt to perform an EMSA with total φCh1 DNA using gp49 that has been 
renatured by gel filtration. Though several bands seem to shift (see Figure 13) the 
experiment itself could only be performed once. Repeated efforts to reproduce the 
initial results failed. In a subsequent experiment, when selected fragments of φCh1 
DNA were tested using gp49 that was purified the same way the results were also 
not convincing (see Figure 14) giving, if any, very tiny shifts. It could be stated that 
as gp49 is with 13.3 kDa a relatively small protein the resulting shifts are also 
small. However, even the small shifts are not very convincing as they seem to be 
“all or nothing” shifts, meaning that either the whole DNA fraction is shifted or 
nothing at all. Taken altogether it seems very unlikely that the data shown in 
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Figure 14 really represent valid band shifts. This brings up the question what 
exactly was observed in these two experiments. When renaturating a protein by 
size exclusion chromatography the denaturing agent is slowly and thoroughly 
removed thus allowing the protein to regain its native conformation. However, 
instead of returning into its active form refolding could as well result in any other 
stable conformation. Thus it seems obvious that smaller proteins are more likely to 
restore their native states than bigger ones simply because fewer amino acids are 
participated in the refolding process. Furthermore it is also apparent that after 
removal of the denaturing agent all possible conformations of the now soluble 
protein are simultaneously available in different concentrations, favoring the most 
stable one.   Therefore though gp49 is a relatively small protein it cannot be tested 
nor assumed that after size exclusion chromatography gp49 has regained its native 
and active conformation. Consequently it is also possible that the shifts observed 
using total φCh1 DNA are due to an impurity, since it seems to be likely that 
proteins smaller than gp49 refold better into their native conformation. 
The experiments, however, that were performed with gp49 solubilized in 4 M urea 
gave somewhat surprising results as it seems that even under these conditions 
gp49 is able to interact with DNA. This leads to the immediate question how 
proteins are able to be active in a denatured state? Maybe the answer lies in a 
paradigm change that lately emerges within protein biochemistry. Recent studies 
have shown that in some cases an intrinsic three dimensional structure of a protein 
is not necessary for its function. Such proteins are called intrinsically disordered 
proteins (IDPs) (Dunker et al., 2001) and have been shown to be involved in 
regulation, signaling and control pathways (Radivojac et al., 2007) including DNA 
binding – for example GCN4, a yeast transcription factor. Here the basic region 
adjacent to the leucine zipper is unstructured and folds into a helical structure only 
upon binding to its cognate site (Weiss et al., 1990). In a study of Ward et al. the 
frequency of native (i.e. intrinsic) disorder in a number of genomes, including 
Archaea, has been estimated. Disordered segments of at least 30 residues were 
predicted for 2 % of the archaeal proteins. Within the Archaea the highest 
abundance of IDPs (5 %) occurs in Halobacterium sp., a close relative of Nab. 
magadii (Ward et al., 2004). A computer prediction for gp49 showed a number of 
disordered residues at the N-terminal, as well as at the C-terminal end. Thus it 
seems likely that this protein does not necessarily need a tertiary structure to bind 
DNA in vitro. However, the results of several EMSAs performed in this work point 
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into the direction of a rather unspecific binding under the applied conditions. Thus 
a situation similar to that of GCN4 seems conceivable. This would suggest that one 
of the two disordered regions of gp49 is responsible for the DNA binding while it is 
possible that recognition of the cognate site is carried out by a tertiary structure 
which is lost upon treatment with 4 M urea.  
The present work also took effort to identify the regions responsible for gp49 
activity. By performing a phage titer analysis comparing five different 3´ deletion 
mutants of gp49 to the wild type protein it was found that the repressor activity of 
gp49 is situated within the first 81 of altogether 117 codons. On the other hand 
EMSAs performed with virtually the same mutants showed that even the smallest 
gp49 derivative, gp49Δ5 consisting only of the first 57 codons, is able to shift DNA 
equally well as the wild type does. These facts suggest that gp49 contains at least 
two domains, one of which being solely responsible for the binding of DNA and the 
other mediating repressor activity. Consequently the DNA binding domain (DBD) 
is located at the N-terminal end of the protein with the initial 57 codons. Studies 
with an N-terminal deletion mutant of gp49 deprived of the first 52 codons support 
this theory since no bandshifts were observed when an EMSA was performed using 
such a protein.   
3.2.8. Closing words 
The present work represents the initial steps of the characterization of a protein 
that has been herein verified to be a repressor of the halophage φCh1. To the 
knowledge of the author this is also the first time that an EMSA using a 
haloalkaliphilic protein could ever be successfully performed. However, the 
characterization of gp49 is by far not completed as for example the nature of the 
repressor activity of gp49 is still unknown, a mechanism further studies will have 
to reveal.  
The third domain of life certainly holds a tremendous amount of yet undiscovered 
knowledge that may proof indispensable for the future. Moreover, though the work 
with Archaea sometimes seems to be extraordinary difficult and cumbersome, 
especially when it comes to extremophiles, it should not be forgotten that research 
on Archaea also contributes an undeniable part to the revelation of evolutionary 
relationships between all living organisms.  
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Abstract 
The halophage φCh1 infects Natrialba magadii, a haloalkaliphilic archaeon facing 
extreme living conditions – high salinity and high pH values. The present work 
contributed to the elucidation of the φCh1 origin of replication as well as to the 
characterization of the φCh1 repressor gp49. 
The φCh1 origin of replication consists of two open reading frames (ORF53 and 
ORF54) similar to RepH, a protein that has been shown to be required for 
replication of plasmid pNRC100 of Haloarcula marismortui. ORF53 is flanked by 
an AT-rich palindromic sequence at the 5´ end while the same is true for ORF54 at 
the 3´ end. Both palindromic sequences are suggested to be involved in the 
mechanism of replication. By introducing a +1 frameshift mutation into ORF53 as 
well as ORF54 this work could provide evidence that both ORFs are absolutely 
required for replication suggesting that in φCh1 ORF53 and ORF54 together 
mediate RepH activity. Furthermore by deleting the 5´ as well as the 3´ AT-rich 
palindromic sequences this work could show that the 3´ sequence seems to be more 
important for replication if only one of these two sequences is deleted. However, 
deleting both sequences has no effect on replication suggesting a so far unknown 
mechanism of replication. 
The second part of this work describes the characterization of gp49 the gene 
product φCh1 ORF49. In an initial phage titer experiment where ORF49 was 
cloned into a Nab. magadii shuttle vector, gp49 could be shown to be a powerful 
φCh1 repressor. By deletion mutagenesis the active domain of gp49 activity was 
mapped to comprise the first 81 of altogether 117 codons.  Furthermore gp49 was 
cloned into an E. coli expression vector from which it could be successfully purified. 
Moreover using gp49 the first EMSA with a haloalkaliphilic protein could be 
performed identifying gp49 as DNA binding protein. Further binding studies with 
truncated forms of gp49 revealed that C-terminal truncations have no effect on 
DNA binding whereas repressor activity is lost. On the other hand an N-terminal 
deletion of the first 52 codons leads to the abolishment of the DNA binding activity. 
These data suggest that gp49 is comprised at least of two domains, one of which 
being responsible for binding the other mediating the repressor activity.  
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Zusammenfassung 
Der Halophage φCh1 infiziert das Archaeon Natrialba magadii, welches in  
extremen Habitaten vorkommt, wo sowohl ein hoher Salzgehalt als auch ein hoher 
pH Wert vorherrschen. Die vorliegende Diplomarbeit beteiligt sich an der näheren 
Aufklärung des Replikationsursprungs von φCh1 sowie an der Charakterisierung 
des φCh1 Repressors gp49. 
Der Replikationsursprung von φCh1 besteht aus zwei offenen Leserahmen (ORFs) 
statt wie gewöhnlich nur aus einem. Beide Leserahmen (ORF53 und ORF54)  
ähneln RepH, einem Faktor der für die Replikation des  Haloarcula marismortui 
Plasmids pNRC100 eine große Rolle spielt. Diese beiden ORFs sind für die 
Replikation eines zuvor entwickelten Shuttle Vektors in Nab. magadii notwendig. 
Die 5´ Region von ORF53 sowie die 3´ Region von ORF54 wird von AT-reichen 
palindromischen Sequenzen flankiert. Beide palindromischen Sequenzen sind 
höchstwahrscheinlich an der Replikation von φCh1 beteiligt. In der vorliegenden 
Arbeit wurden ORF53  sowie ORF54 durch eine Mutation, welche den Leserahmen 
der Gene um jeweils +1 verschiebt, zerstört. So konnte zweifelsfrei gezeigt werden, 
dass beide ORFs für die Replikation des Nab. magadii Shuttle Vektors absolut 
notwendig sind. Dadurch steht es nunmehr außer Frage, dass in φCh1 beide 
Leserahmen für die RepH Aktivität verantwortlich sind. Durch die Deletion der 5´ 
sowie der 3´ AT-reichen Sequenzen konnte in dieser Arbeit gezeigt werden, dass 
die 3´ Sequenz eine größere Rolle spielt, wenn nur jeweils eine der beiden 
Sequenzen deletiert ist. Gleichzeitige Deletion beider Sequenzen stellt allerdings 
das normale Replikationsverhalten wieder her, was auf einen bisher unbekannten 
Replikationsmechanismus hindeutet.  
Der zweite Teil dieser Arbeit befasst sich mit der Charakterisierung von gp49, dem 
Genprodukt des ORF49. In einem anfänglichen Phagentiterexperiment, bei dem 
ORF49 auf den Nab. magadii Shuttle Vektor kloniert wurde, konnte eine 
eindeutige Repressoraktivität von gp49 festgestellt werden. Durch Kartierung 
mittels Deletionsmutagenese konnte die aktive Domäne des Proteins auf die ersten 
81 von insgesamt 117 Codons festgelegt werden. Darüberhinaus wurde gp49 in 
einen E. coli Expressionsvektor kloniert, von dort aus exprimiert und erfolgreich 
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aufgereinigt. Mit dem aufgereingten Produkt konnte der erste EMSA mit einem 
haloalkalophilen Protein durchgeführt werden, was den Nachweis der  
DNA-Bindungsaktivität von gp49 lieferte. Weitere Bindungsstudien mit 
verkürzten Versionen von gp49 ergaben, dass C-terminale Deletionen keinen 
Effekt auf die DNA – Bindungsaktivität haben, während die Repressoraktivität 
zerstört wird. Werden hingegen die ersten 52 N-terminalen Codons deletiert, geht 
die Bindungsaktivität verloren. Damit konnte gezeigt werden, dass gp49 aus 
mindestens zwei funktionellen Domänen besteht, einer Domäne, die für die  
DNA – Bindung verantwortlich ist und einer Domäne, welche die Aktivität des 
Proteins vermittelt. 
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